EIF2B4 encodes the delta subunit of eukaryotic translation initiation factor 2B (eIF2B), a heterodecameric guanine nucleotide exchange factor (GEF) essential for translation initiation. The delta subunit, together with alpha and beta subunits, forms the regulatory subcomplex that senses cellular stress signals, particularly through binding phosphorylated eIF2alpha. The eIF2B complex catalyzes GDP-GTP exchange on eIF2, regenerating active eIF2-GTP complexes required for continued protein synthesis. EIF2B4 is critical for the integrated stress response (ISR), where phosphorylated eIF2alpha binds at the interface between eIF2Balpha and eIF2Bdelta subunits, inhibiting GEF activity and reducing global translation. eIF2Bdelta is a regulatory/scaffold (noncatalytic) subunit that contributes to decameric holoenzyme assembly and is part of the beta/delta core that supports allosteric regulation by small molecules such as ISRIB. In mammalian cells, eIF2B (including the delta subunit) localizes to discrete cytoplasmic "eIF2B bodies" whose subunit composition is cell-type specific and which represent sites of GEF activity (PMID:39310746). Mutations in EIF2B4 cause vanishing white matter disease (leukoencephalopathy with VWM) and ovarioleukodystrophy, demonstrating the essential role of this subunit in normal eIF2B function, particularly in oligodendrocytes and astrocytes.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0002183
cytoplasmic translational initiation
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: EIF2B4 is part of the eIF2B complex that functions in the cytoplasm to catalyze GDP-GTP exchange on eIF2, which is essential for cytoplasmic translation initiation. This annotation is well-supported by phylogenetic analysis and the deep research showing eIF2B is a cytosolic complex essential for translation initiation [PMID:11323413].
Reason: The IBA annotation is appropriate. EIF2B4 is a component of the eIF2B complex, which is the sole GEF for eIF2 and is required for cytoplasmic translation initiation. The deep research confirms "eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis."
Supporting Evidence:
PMID:11323413
Initiation factor eIF2B mediates a key regulatory step in the initiation of mRNA translation, i.e. the regeneration of active eIF2.GTP complexes.
file:human/EIF2B4/EIF2B4-deep-research-openai.md
eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis
|
|
GO:0005851
eukaryotic translation initiation factor 2B complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: EIF2B4 encodes the delta subunit of the eIF2B complex, which is a heterodecameric assembly. The delta subunit is part of the regulatory subcomplex along with alpha and beta subunits. Cryo-EM structures have confirmed the architecture of the complex [PMID:29599213].
Reason: The delta subunit is a core component of the eIF2B complex. UniProt confirms "Component of the translation initiation factor 2B (eIF2B) complex which is a heterodecamer of two sets of five different subunits: alpha, beta, gamma, delta and epsilon."
Supporting Evidence:
PMID:29599213
Formation of fully active, decameric eIF2B holoenzyme depended on the assembly of two identical tetrameric subcomplexes
PMID:11323413
It is composed of five subunits, alpha-epsilon.
PMID:24532666
Analysis of the subunit organization of the eIF2B complex reveals new insights into its structure and regulation
file:human/EIF2B4/EIF2B4-deep-research-falcon.md
eIF2B is a decamer composed of two copies of each of five subunits (α–ε) and place δ (EIF2B4) among the regulatory subunits (α/β/δ) rather than the catalytic subunits (γ/ε)
|
|
GO:0003743
translation initiation factor activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: This IEA annotation from UniProtKB keyword mapping is appropriate as EIF2B4 is part of eIF2B, which functions as a translation initiation factor by regenerating active eIF2-GTP complexes needed for translation initiation [PMID:16289705].
Reason: EIF2B4 as part of the eIF2B complex contributes to translation initiation factor activity. PMID:16289705 demonstrates that "eIF2 and eIF2B augmented translation" in cell-free systems, confirming the translation initiation factor activity. Note that EIF2B4 itself does not have direct catalytic activity (catalytic core is in epsilon/gamma subunits) but contributes to the overall activity of the complex.
Supporting Evidence:
PMID:16289705
eIF2 (eukaryotic translation initiation factor 2) and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs.
|
|
GO:0005085
guanyl-nucleotide exchange factor activity
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: The eIF2B complex has GEF activity, catalyzing GDP-GTP exchange on eIF2. While the catalytic activity resides primarily in the epsilon subunit, the delta subunit is required for full GEF activity as part of the regulatory subcomplex.
Reason: The IEA annotation correctly identifies that the eIF2B complex has GEF activity. PMID:11323413 directly characterizes "the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein." The delta subunit contributes to this activity as part of the holoenzyme.
Supporting Evidence:
PMID:11323413
mammalian eIF2B can mediate release of eIF2-bound GDP even in the absence of free nucleotide, indicating that it acts as a GDP dissociation stimulator protein
file:human/EIF2B4/EIF2B4-deep-research-falcon.md
eIF2B is the GEF for eIF2, recycling inactive eIF2–GDP to active eIF2–GTP, thereby replenishing the pool of eIF2 needed to form the ternary complex (eIF2–GTP·Met-tRNAi) and initiate translation
|
|
GO:0005829
cytosol
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: EIF2B4 localizes to the cytosol as part of the eIF2B complex, where translation initiation occurs. Deep research confirms "The EIF2B4 gene product (eIF2Bdelta) carries out its function in the cytosol, where translation initiation occurs." Recent work shows eIF2B localizes to discrete cytoplasmic eIF2B bodies (sites of GEF activity) with cell-type-specific composition including the delta subunit (PMID:39310746).
Reason: The cytosolic localization is well-established for eIF2B subunits. UniProt annotation states "Cytoplasm, cytosol" with ECO:0000250 evidence from S. pombe ortholog. This is consistent with the function in cytoplasmic translation initiation.
Supporting Evidence:
file:human/EIF2B4/EIF2B4-deep-research-openai.md
The EIF2B4 gene product (eIF2Bdelta) carries out its function in the cytosol, where translation initiation occurs.
PMID:39310746
eIF2B localization and its regulation during the integrated stress response is cell-type specific
|
|
GO:0005851
eukaryotic translation initiation factor 2B complex
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Duplicate annotation (different evidence source from IBA above) confirming EIF2B4 as a component of the eIF2B complex.
Reason: This IEA annotation reinforces that EIF2B4 is part of the eIF2B complex. Multiple evidence lines supporting the same conclusion is appropriate.
Supporting Evidence:
PMID:29599213
Formation of fully active, decameric eIF2B holoenzyme depended on the assembly of two identical tetrameric subcomplexes
|
|
GO:0006412
translation
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: EIF2B4 is involved in translation as part of the eIF2B complex, which is essential for regenerating active eIF2-GTP complexes required for translation initiation.
Reason: The involvement in translation is well-established. The deep research states "eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis." GO:0006413 (translational initiation) would be more specific, but this parent term is also accurate.
Supporting Evidence:
PMID:16289705
eIF2 (eukaryotic translation initiation factor 2) and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs.
|
|
GO:0006413
translational initiation
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: EIF2B4 is involved in translational initiation as part of the eIF2B complex, which regenerates eIF2-GTP needed for initiating translation of mRNAs.
Reason: The role in translational initiation is directly supported by literature. PMID:11323413 states "Initiation factor eIF2B mediates a key regulatory step in the initiation of mRNA translation."
Supporting Evidence:
PMID:11323413
Initiation factor eIF2B mediates a key regulatory step in the initiation of mRNA translation, i.e. the regeneration of active eIF2.GTP complexes.
|
|
GO:0007417
central nervous system development
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: This annotation is derived from ARBA machine learning. While EIF2B4 mutations cause vanishing white matter disease affecting the CNS, the role of EIF2B4 in CNS development is indirect - through its essential role in translation rather than a specific developmental function.
Reason: EIF2B4 is essential for protein synthesis, which is required for all developmental processes. The CNS is particularly sensitive to EIF2B deficiency as shown in VWM disease, but this reflects the high protein synthesis demands of oligodendrocytes rather than a specific developmental role. This is a pleiotropic/secondary effect rather than a core function.
Supporting Evidence:
PMID:15217090
Vanishing white matter disease (VWM) is a progressive cavitating disease of central white matter due to a deficiency of the translation initiation factor eIF2B.
|
|
GO:0048513
animal organ development
|
IEA
GO_REF:0000117 |
REMOVE |
Summary: This IEA annotation is too general and reflects the essential nature of protein synthesis (requiring eIF2B) for all developmental processes rather than a specific function of EIF2B4.
Reason: This is an over-annotation. EIF2B4 is essential for global protein synthesis, which is required for all cellular processes including organ development. However, there is no evidence that EIF2B4 plays a specific role in organ development beyond enabling general translation. The annotation is too broad and not informative for this gene.
Supporting Evidence:
file:human/EIF2B4/EIF2B4-deep-research-openai.md
eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
REMOVE |
Summary: Generic protein binding annotation from high-throughput interactome mapping. EIF2B4 binds to EIF2B2 as part of the eIF2B complex.
Reason: GO curation guidelines discourage use of the generic "protein binding" term when more specific terms are available. The interaction with EIF2B2 is better captured by the eIF2B complex membership annotation (GO:0005851). More specific terms like "translation initiation factor binding" (GO:0031369) are also annotated.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network
|
|
GO:0005515
protein binding
|
IPI
PMID:25910212 Widespread macromolecular interaction perturbations in human... |
REMOVE |
Summary: High-throughput interaction study showing EIF2B4 interacts with EIF2B2.
Reason: The generic "protein binding" term is not informative. The interaction between EIF2B4 and EIF2B2 is well-characterized as part of the eIF2B complex structure. This is better represented by the complex membership annotation.
Supporting Evidence:
PMID:25910212
Widespread macromolecular interaction perturbations in human genetic disorders
|
|
GO:0005515
protein binding
|
IPI
PMID:28169297 Comparative influenza protein interactomes identify the role... |
REMOVE |
Summary: This study identified interactions between influenza viral proteins and host proteins including EIF2B4. The biological significance of these interactions to EIF2B4's core function is unclear.
Reason: Generic protein binding is uninformative. The viral protein interactions may represent viral hijacking of the translation machinery but do not inform about EIF2B4's core molecular function.
Supporting Evidence:
PMID:28169297
Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction
|
|
GO:0005515
protein binding
|
IPI
PMID:29599245 Binding of ISRIB reveals a regulatory site in the nucleotide... |
REMOVE |
Summary: Study examining binding of ISRIB to eIF2B complex including EIF2B4.
Reason: The generic "protein binding" term does not capture the functional relevance. The ISRIB binding affects eIF2B activity but is better understood in the context of GEF activity regulation. The small molecule binding is not well captured by "protein binding."
Supporting Evidence:
PMID:29599245
Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B
|
|
GO:0005515
protein binding
|
IPI
PMID:31515488 Extensive disruption of protein interactions by genetic vari... |
REMOVE |
Summary: High-throughput study on protein-protein interactions across human populations.
Reason: Generic protein binding annotation from high-throughput study is not informative. More specific molecular function terms are available.
Supporting Evidence:
PMID:31515488
Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
REMOVE |
Summary: Human binary interactome mapping study.
Reason: Generic protein binding from high-throughput interactome study is not informative for annotation purposes. The specific interactions of EIF2B4 within the eIF2B complex and with eIF2 are better captured by other annotations.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
REMOVE |
Summary: Study on interactome mapping in neurodegenerative disease.
Reason: Generic protein binding is not informative. While EIF2B4 mutations cause neurodegeneration, the relevant molecular function is its role in the eIF2B complex with GEF activity, not generic protein binding.
Supporting Evidence:
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
REMOVE |
Summary: Dual proteome-scale network study on cell-specific interactomes.
Reason: Generic protein binding is uninformative. Better molecular function terms exist.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome
|
|
GO:0005851
eukaryotic translation initiation factor 2B complex
|
IPI
PMID:29599213 Structure of the nucleotide exchange factor eIF2B reveals me... |
ACCEPT |
Summary: Cryo-EM structural study demonstrating EIF2B4 (delta subunit) is part of the eIF2B decameric complex. This study solved the atomic structure of the complex.
Reason: Excellent experimental evidence from structural studies. PMID:29599213 states "Formation of fully active, decameric eIF2B holoenzyme depended on the assembly of two identical tetrameric subcomplexes."
Supporting Evidence:
PMID:29599213
we solved an atomic-resolution structure of ISRIB bound in a deep cleft within decameric human eIF2B by cryo-electron microscopy
|
|
GO:0045948
positive regulation of translational initiation
|
IDA
PMID:29599213 Structure of the nucleotide exchange factor eIF2B reveals me... |
ACCEPT |
Summary: The eIF2B complex positively regulates translation initiation by catalyzing GDP-GTP exchange on eIF2, thereby regenerating active eIF2-GTP complexes.
Reason: This annotation correctly captures the regulatory role of eIF2B. The deep research confirms that "eIF2B enables continuous rounds of translation initiation" by recycling eIF2-GDP to eIF2-GTP.
Supporting Evidence:
PMID:29599213
Formation of fully active, decameric eIF2B holoenzyme depended on the assembly of two identical tetrameric subcomplexes
file:human/EIF2B4/EIF2B4-deep-research-openai.md
By recycling eIF2-GDP to eIF2-GTP, eIF2B enables continuous rounds of translation initiation
|
|
GO:0002183
cytoplasmic translational initiation
|
IDA
PMID:27023709 Expression, purification, and crystallization of Schizosacch... |
ACCEPT |
Summary: Study on expression and crystallization of S. pombe eIF2B, providing functional evidence for the role of eIF2B subunits in cytoplasmic translation initiation.
Reason: EIF2B4 is part of the eIF2B complex essential for cytoplasmic translation initiation. The IDA evidence from this study supports the annotation.
Supporting Evidence:
PMID:27023709
Expression, purification, and crystallization of Schizosaccharomyces pombe eIF2B
|
|
GO:0005085
guanyl-nucleotide exchange factor activity
|
IDA
PMID:25858979 Stress responses. Mutations in a translation initiation fact... |
ACCEPT |
Summary: This landmark study identified the target of ISRIB (a memory-enhancing compound) as eIF2B and confirmed the GEF activity of the complex. Mutations in the delta subunit affected ISRIB's stimulatory effect on eIF2B GEF activity.
Reason: Strong experimental evidence. The study states that ISRIB affected "its stimulatory effect on eIF2B GEF activity toward its substrate, the translation initiation factor eIF2, in vitro." Mutations in the delta subunit affected this activity, demonstrating EIF2B4's contribution to GEF function.
Supporting Evidence:
PMID:25858979
these mutations reversed both ISRIB-mediated inhibition of the ISR and its stimulatory effect on eIF2B GEF activity toward its substrate, the translation initiation factor eIF2, in vitro
|
|
GO:0005085
guanyl-nucleotide exchange factor activity
|
IDA
PMID:27023709 Expression, purification, and crystallization of Schizosacch... |
ACCEPT |
Summary: Study providing functional evidence for eIF2B GEF activity through structural and biochemical characterization.
Reason: Multiple lines of evidence confirm eIF2B's GEF activity. This annotation is consistent with the well-established function of the eIF2B complex.
Supporting Evidence:
PMID:27023709
Expression, purification, and crystallization of Schizosaccharomyces pombe eIF2B
|
|
GO:0005851
eukaryotic translation initiation factor 2B complex
|
IDA
PMID:27023709 Expression, purification, and crystallization of Schizosacch... |
ACCEPT |
Summary: Direct evidence for EIF2B4 as a component of the eIF2B complex from crystallization studies.
Reason: Strong experimental evidence from structural studies confirming the delta subunit's membership in the eIF2B complex.
Supporting Evidence:
PMID:27023709
Expression, purification, and crystallization of Schizosaccharomyces pombe eIF2B
|
|
GO:0050852
T cell receptor signaling pathway
|
IDA
PMID:8626696 T-cell activation leads to rapid stimulation of translation ... |
KEEP AS NON CORE |
Summary: Study showing that T-cell activation leads to rapid stimulation of eIF2B activity and inactivation of GSK-3. The eIF2B activity increases within 5 minutes of T-cell stimulation.
Reason: This annotation reflects that eIF2B is regulated downstream of T-cell receptor signaling through GSK-3 inactivation, rather than EIF2B4 having a direct role in TCR signaling itself. The study states "The rapid activation of EIF2B following mitogenic stimulation of T-cells is therefore mediated by factors other than its own concentration." This is a regulatory context rather than a direct signaling function.
Supporting Evidence:
PMID:8626696
Mitogenic stimulation of T-lymphocytes causes a rapid activation or protein synthesis... eIF2B activity rises quickly, increasing as early as 5 min after cell stimulation
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-72670 |
ACCEPT |
Summary: Reactome pathway annotation for formation of eIF2:GDP:eIF2B intermediate, which occurs in the cytosol.
Reason: The cytosolic localization is consistent with the function in translation initiation, which occurs in the cytoplasm.
Supporting Evidence:
Reactome:R-HSA-72670
Formation of eIF2:GDP:eIF2B intermediate
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-72722 |
ACCEPT |
Summary: Reactome pathway annotation for eIF2 activation, which occurs in the cytosol.
Reason: Consistent with cytosolic localization for translation initiation function.
Supporting Evidence:
file:human/EIF2B4/EIF2B4-deep-research-openai.md
The EIF2B4 gene product (eIF2Bdelta) carries out its function in the cytosol, where translation initiation occurs.
|
|
GO:0031369
translation initiation factor binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: EIF2B4 binds to eIF2 (the substrate of the eIF2B complex) as part of the nucleotide exchange mechanism. This is inferred from sequence similarity to rat ortholog.
Reason: The deep research confirms that "eIF2 binds across the decameric interface, engaging the eIF2B alpha subunit, and beta and delta subunits" (PMID:29599213). This directly demonstrates translation initiation factor binding by EIF2B4.
Supporting Evidence:
PMID:29599213
eIF2 binds across the decameric interface, engaging the eIF2B alpha subunit, and beta and delta subunits from opposing tetramers
|
|
GO:0006413
translational initiation
|
IDA
PMID:16289705 An efficient mammalian cell-free translation system suppleme... |
ACCEPT |
Summary: Study demonstrating that supplementation with eIF2B enhances translation in mammalian cell-free systems.
Reason: Direct experimental evidence showing that eIF2B augments translation. The study states "eIF2 and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs."
Supporting Evidence:
PMID:16289705
eIF2 (eukaryotic translation initiation factor 2) and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs.
|
|
GO:0009408
response to heat
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: EIF2B is regulated as part of the integrated stress response, which includes heat stress. Inferred from sequence similarity to rat ortholog.
Reason: EIF2B4 is part of the eIF2B complex that is regulated during the integrated stress response. Heat stress causes eIF2alpha phosphorylation, which inhibits eIF2B activity. This is a response to stress rather than a core function. The deep research confirms "In response to various stresses (e.g. nutrient starvation, viral infection, ER stress), specialized kinases... phosphorylate eIF2 on its alpha subunit."
Supporting Evidence:
file:human/EIF2B4/EIF2B4-deep-research-openai.md
In response to various stresses (e.g. nutrient starvation, viral infection, ER stress), specialized kinases such as PKR, GCN2, PERK, and HRI phosphorylate eIF2 on its alpha subunit at Ser51
|
|
GO:0009408
response to heat
|
TAS
PMID:12499492 A severe variant of childhood ataxia with central hypomyelin... |
KEEP AS NON CORE |
Summary: Study describing vanishing white matter disease related to EIF2B5 mutation, noting that fever (heat stress) triggers neurological deterioration.
Reason: Heat stress triggers the integrated stress response, which modulates eIF2B activity. This is a regulatory context rather than a direct function of EIF2B4. In VWM patients, "additional episodes of rapid deterioration following febrile infections" are common, demonstrating that heat/fever affects eIF2B-dependent cells.
Supporting Evidence:
PMID:12499492
A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation
|
|
GO:0014003
oligodendrocyte development
|
IMP
PMID:15217090 The life and death of oligodendrocytes in vanishing white ma... |
KEEP AS NON CORE |
Summary: Study on vanishing white matter disease showing that oligodendrocytes are affected by eIF2B deficiency. The study documents increased oligodendrocyte density with evidence of both apoptosis and proliferation.
Reason: The phenotype in VWM disease reflects the high protein synthesis demands of oligodendrocytes, making them particularly sensitive to eIF2B deficiency. This is a secondary/pleiotropic effect of impaired translation rather than a specific developmental role. The study states "Vanishing white matter disease (VWM) is a progressive cavitating disease of central white matter due to a deficiency of the translation initiation factor eIF2B."
Supporting Evidence:
PMID:15217090
Vanishing white matter disease (VWM) is a progressive cavitating disease of central white matter due to a deficiency of the translation initiation factor eIF2B. Oligodendrocytes appear to be numerically increased in some white matter areas, while decreased in others.
|
|
GO:0003743
translation initiation factor activity
|
IDA
PMID:16289705 An efficient mammalian cell-free translation system suppleme... |
ACCEPT |
Summary: Direct experimental evidence showing eIF2B enhances translation in cell-free systems. The annotation uses "contributes_to" qualifier, which is appropriate since the catalytic activity is primarily in the epsilon subunit.
Reason: This annotation correctly captures that EIF2B4 contributes to (rather than directly enables) translation initiation factor activity as part of the eIF2B complex. The catalytic core is in epsilon/gamma subunits, but the delta subunit is required for full activity.
Supporting Evidence:
PMID:16289705
eIF2 (eukaryotic translation initiation factor 2) and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs.
|
|
GO:0009749
response to glucose
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: eIF2B activity is regulated by metabolic signals including glucose levels, through insulin signaling and GSK-3 phosphorylation of eIF2Bepsilon.
Reason: eIF2B is regulated by metabolic signals but this is not a core function. The deep research notes that "insulin signaling blocks GSK-3, leading to Ser535 dephosphorylation and enhanced eIF2B function." This represents regulation of eIF2B activity by metabolic state rather than a direct response to glucose by EIF2B4.
Supporting Evidence:
file:human/EIF2B4/EIF2B4-deep-research-openai.md
insulin - through the PI3K/Akt pathway - activates eIF2B by inhibiting GSK-3 kinase
|
|
GO:0043434
response to peptide hormone
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: eIF2B activity is modulated by insulin (a peptide hormone) through the GSK-3 pathway. Inferred from sequence similarity to rat ortholog.
Reason: eIF2B is regulated downstream of insulin signaling, but this is a regulatory context rather than a core function of EIF2B4. The annotation reflects that eIF2B is part of a pathway responding to peptide hormones rather than directly sensing them.
Supporting Evidence:
PMID:8626696
The largest (epsilon) subunit of eIF2B is a substrate for glycogen synthase kinase-3 (GSK-3), the activity of which rapidly decreases following T-cell activation.
|
|
GO:0005515
protein binding
|
IPI
PMID:15060152 Mutations linked to leukoencephalopathy with vanishing white... |
REMOVE |
Summary: Study examining mutations linked to vanishing white matter disease and their effects on eIF2B complex function and interactions with EIF2B2.
Reason: Generic protein binding is not informative. The relevant interaction (with EIF2B2 and other eIF2B subunits) is better captured by the eIF2B complex membership annotation.
Supporting Evidence:
PMID:15060152
Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways
|
|
GO:0001541
ovarian follicle development
|
IMP
PMID:15507143 Screening for known mutations in EIF2B genes in a large pane... |
KEEP AS NON CORE |
Summary: Study screening for EIF2B mutations in patients with premature ovarian failure. Some EIF2B4 mutations cause ovarioleukodystrophy.
Reason: The ovarian phenotype in VWM/ovarioleukodystrophy reflects the sensitivity of rapidly dividing cells to translation defects. UniProt notes that mutations cause "ovarian failure" and "ovarioleukodystrophy." However, this is a secondary effect of impaired global translation rather than a specific role in ovarian development.
Supporting Evidence:
PMID:15507143
Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure
PMID:39139316
This resulted in a series of 20 cases of women with ovarioleukodystrophy due to variants in the EIF2B gene complex. The median age of onset was 19 years (range 0.6-40). The clinical features present in the entire sample were WM involvement and ovarian changes, the latter corresponding to ovarian dysgenesis (5%), primary amenorrhea (15%), secondary amenorrhea (15%), and premature ovarian failure (60%)
|
|
GO:0005085
guanyl-nucleotide exchange factor activity
|
IDA
PMID:11323413 Characterization of the mammalian initiation factor eIF2B co... |
ACCEPT |
Summary: Seminal study characterizing mammalian eIF2B as a GDP dissociation stimulator protein. Demonstrated that eIF2B can mediate release of eIF2-bound GDP.
Reason: Strong experimental evidence. The study directly demonstrates GEF activity: "mammalian eIF2B can mediate release of eIF2-bound GDP even in the absence of free nucleotide, indicating that it acts as a GDP dissociation stimulator protein." Note: the annotation uses "contributes_to" qualifier, which is appropriate as catalytic activity is primarily in epsilon subunit.
Supporting Evidence:
PMID:11323413
mammalian eIF2B can mediate release of eIF2-bound GDP even in the absence of free nucleotide, indicating that it acts as a GDP dissociation stimulator protein
file:human/EIF2B4/EIF2B4-deep-research-falcon.md
eIF2B's catalytic function is mainly attributed to the γ and ε subunits, while α/β/δ enhance full activity and provide regulatory control, including stress sensitivity
|
|
GO:0005737
cytoplasm
|
IDA
PMID:11323413 Characterization of the mammalian initiation factor eIF2B co... |
ACCEPT |
Summary: Study demonstrating eIF2B function in the cytoplasm through biochemical characterization of the complex.
Reason: The cytoplasmic localization is well-established and consistent with the function in translation initiation, which occurs in the cytoplasm.
Supporting Evidence:
PMID:11323413
Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein
|
|
GO:0005851
eukaryotic translation initiation factor 2B complex
|
IDA
PMID:11323413 Characterization of the mammalian initiation factor eIF2B co... |
ACCEPT |
Summary: Study characterizing the five-subunit eIF2B complex, confirming EIF2B4 (delta) as a component.
Reason: Direct experimental evidence. The study states "It is composed of five subunits, alpha-epsilon."
Supporting Evidence:
PMID:11323413
It is composed of five subunits, alpha-epsilon.
PMID:24532666
is actually decameric, a dimer of eIF2B(βγδε) tetramers stabilized by 2 copies
|
|
GO:0042552
myelination
|
IMP
PMID:14566705 eIF2B-related disorders: antenatal onset and involvement of ... |
KEEP AS NON CORE |
Summary: Study on eIF2B-related disorders showing that mutations cause myelination defects. Vanishing white matter disease involves loss of myelin.
Reason: The myelination phenotype in VWM reflects the high protein synthesis demands of myelinating oligodendrocytes. This is a secondary/pleiotropic effect of impaired translation rather than a direct role in myelination. The annotation is valid as a mutant phenotype but not a core function of EIF2B4.
Supporting Evidence:
PMID:14566705
eIF2B-related disorders: antenatal onset and involvement of multiple organs
|
|
GO:0005085
guanyl-nucleotide exchange factor activity
|
IMP
PMID:15054402 Decreased guanine nucleotide exchange factor activity in eIF... |
ACCEPT |
Summary: Study measuring GEF activity in cells from patients with eIF2B mutations. Demonstrated 20-70% decrease in GEF activity in mutated cells.
Reason: Strong functional evidence. The study states "A significant decrease of 20-70% in GEF activity was observed in all mutated cells." This demonstrates that EIF2B4 mutations affect GEF activity. Uses "contributes_to" qualifier appropriately.
Supporting Evidence:
PMID:15054402
A significant decrease of 20-70% in GEF activity was observed in all mutated cells. The severity of this decrement of GEF activity correlated with age at onset of the disease.
|
|
GO:0005851
eukaryotic translation initiation factor 2B complex
|
IDA
PMID:15060152 Mutations linked to leukoencephalopathy with vanishing white... |
ACCEPT |
Summary: Study on mutations affecting eIF2B complex function, confirming EIF2B4 as a component of the complex.
Reason: Direct experimental evidence from studies of the eIF2B complex.
Supporting Evidence:
PMID:15060152
Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways
|
|
GO:0006417
regulation of translation
|
NAS
PMID:12556349 Reduced amino acid availability inhibits muscle protein synt... |
ACCEPT |
Summary: Study showing that reduced amino acid availability inhibits muscle protein synthesis and decreases eIF2B activity.
Reason: eIF2B is a key regulator of translation. The deep research confirms that "eIF2B activity is regulated during the integrated stress response" and "By assembling these subunits, eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis."
Supporting Evidence:
PMID:12556349
Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B
PMID:36943285
Phosphorylation of eIF2α (p-eIF2α) blocks the eIF2B-directed exchange, consequently reducing the levels of eIF2•GTP that are required for delivery of methionyl initiator tRNA
file:human/EIF2B4/EIF2B4-deep-research-falcon.md
phosphorylated eIF2α binds eIF2B in a way that blocks productive engagement of eIF2γ with the catalytic ε subunit, suppressing nucleotide exchange
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The research target is human EIF2B4, encoding translation initiation factor eIF2B subunit delta (eIF2Bδ) (UniProt Q9UI10)—a regulatory/scaffold component of the heterodecameric eIF2B complex. Multiple sources consistently describe eIF2B as a decamer composed of two copies of each of five subunits (α–ε) and place δ (EIF2B4) among the regulatory subunits (α/β/δ) rather than the catalytic subunits (γ/ε). (wortham2014analysisofthe pages 9-10, hanson2024eif2blocalizationand pages 1-2)
eIF2B is the GEF for eIF2, recycling inactive eIF2–GDP to active eIF2–GTP, thereby replenishing the pool of eIF2 needed to form the ternary complex (eIF2–GTP·Met-tRNAi) and initiate translation. (wek2023survivingandadapting pages 1-2)
Mechanistically, eIF2B’s catalytic function is mainly attributed to the γ and ε subunits, while α/β/δ enhance full activity and provide regulatory control, including stress sensitivity. (hanson2023theroleof pages 38-42, hanson2024eif2blocalizationand pages 1-2)
The integrated stress response (ISR) is a conserved translational control pathway in which stress-activated kinases phosphorylate eIF2α at Ser51; phosphorylated eIF2α inhibits eIF2B, reducing eIF2–GTP and lowering ternary complex levels, producing a global reduction in translation while permitting selective translation of ISR mRNAs (e.g., ATF4). (hanson2024eif2blocalizationand pages 1-2, wek2023survivingandadapting pages 1-2)
A key mechanistic concept relevant to EIF2B4 is that phosphorylated eIF2α binds eIF2B in a way that blocks productive engagement of eIF2γ with the catalytic ε subunit, suppressing nucleotide exchange. (hanson2024eif2blocalizationand pages 1-2, ghahnavieh2024therapeuticpotentialof pages 34-38)
EIF2B4/eIF2Bδ is best understood as a regulatory/scaffold subunit that:
- participates in assembly and stabilization of the full decameric eIF2B complex (wortham2014analysisofthe pages 9-10, wortham2014analysisofthe pages 4-5)
- contributes to the β/δ “core” that supports higher-order assembly of eIF2B and is central to allosteric regulation by small molecules (ghahnavieh2024therapeuticpotentialof pages 34-38, hanson2023theroleof pages 45-50)
- is implicated in the inhibitory interface for phospho-eIF2α, with mechanistic summaries placing phospho-eIF2α binding at an interface that includes eIF2Bδ (EIF2B4) (ghahnavieh2024therapeuticpotentialof pages 34-38)
A 2024 peer-reviewed study reported that eIF2B localizes to discrete cytoplasmic foci called eIF2B bodies, which are interpreted as sites of eIF2B GEF activity and exhibit cell-type-specific composition in neuronal and glial cell lines. (hanson2024eif2blocalizationand pages 1-2, hanson2024eif2blocalizationand pages 2-4)
In these data, eIF2Bδ inclusion differs by body size and cell type. Baseline co-localization of δ with small eIF2B bodies was reported as 20.83% (SH-SY5Y), 10.63% (U373), and 9.03% (MO3.13); for large eIF2B bodies, δ co-localization was 62.39% (SH-SY5Y), 67.48% (U373), and 65.00% (MO3.13). (hanson2024eif2blocalizationand pages 2-4, hanson2024eif2blocalizationand media e26945f7)
Primary figure evidence for eIF2B bodies, quantification of δ inclusion, and a working model of body composition/regulation are shown in the retrieved figure set. (hanson2024eif2blocalizationand media e26945f7)
A 2023 PNAS study reported that breast cancer stem cells (CSCs) have reduced miR-183, which increases eIF2Bδ protein. Elevated eIF2Bδ was reported to suppress strong ISR induction via preferential interaction with phospho-eIF2α and was required for CSC invasion/metastasis in animal models, highlighting EIF2B4/eIF2Bδ as a functional node connecting translational control to cancer progression. (gupta2023eif2bδblocksthe pages 1-2)
A 2023 review in Antioxidants & Redox Signaling provides an authoritative synthesis: eIF2α phosphorylation blocks eIF2B exchange activity, lowering eIF2–GTP and inhibiting pre-initiation complex formation, while enabling preferential translation of specific stress-responsive mRNAs. (wek2023survivingandadapting pages 1-2)
Recent clinical genetics continues to identify EIF2B4 variants in leukodystrophy diagnostic workflows. A 2023 pediatric cohort study (genetic white matter disorders) included EIF2B4 variants (n=2) and reported a novel splice-site variant EIF2B4 c.885+2T>G. (dong2023genotypicandphenotypic pages 2-4)
Small-molecule eIF2B activators such as ISRIB (and related compounds like 2BAct) are described as agents that bind eIF2B and reduce sensitivity to phospho-eIF2α, thereby restoring translation under ISR conditions. (wek2023survivingandadapting pages 5-6)
Mechanistically relevant to EIF2B4, ISRIB is described as binding at a symmetric interface involving β and δ and promoting higher-order assembly (octamer/decamer) that increases available GEF activity. (hanson2023theroleof pages 45-50)
ClinicalTrials.gov listings indicate individualized interventional efforts for Cree leukoencephalopathy / vanishing white matter disease:
- NCT07272525 (Early Phase 1; enrollment 1; active not recruiting): https://clinicaltrials.gov/study/NCT07272525 (OpenTargets Search: -EIF2B4)
- NCT07300397 (Interventional; enrollment 1; active not recruiting): https://clinicaltrials.gov/study/NCT07300397 (OpenTargets Search: -EIF2B4)
These are not EIF2B4-specific trials in the retrieved registry excerpts, but they represent real-world therapeutic attempts in the eIF2B-related leukodystrophy space. (OpenTargets Search: -EIF2B4)
Across mechanistic sources, the dominant view is that EIF2B4/eIF2Bδ is not the catalytic GEF subunit (γ/ε are catalytic) but is crucial for:
- forming/stabilizing the decameric holoenzyme needed for full physiological function (wortham2014analysisofthe pages 9-10)
- enabling the complex’s proper regulatory behavior under stress (inhibition by phospho-eIF2α and allosteric modulation by ISRIB-class ligands) (hanson2024eif2blocalizationand pages 1-2, hanson2023theroleof pages 45-50)
This delineation explains why many disease and pharmacology effects arise from “noncatalytic” subunits: they govern assembly/state equilibria and inhibitor/activator sensitivity. (wortham2014analysisofthe pages 9-10, hanson2023theroleof pages 45-50)
The 2024 eIF2B-body study advances a framework in which eIF2B is organized into cytoplasmic “bodies” whose subunit composition (including δ) varies by cell type and stress state, providing a plausible explanation for tissue/cell-type selectivity in eIF2B-pathies (e.g., glial vulnerability in VWM). (hanson2024eif2blocalizationand pages 2-4, hanson2024eif2blocalizationand media e26945f7)
A 2024 systematic review and case report compiled 20 ovarioleukodystrophy cases worldwide from 14 reports, with median onset 19 years (range 0.6–40). Ovarian presentations were reported as premature ovarian failure (60%), primary amenorrhea (15%), secondary amenorrhea (15%), and ovarian dysgenesis (5%). Neurologic manifestations included pyramidal/gait disturbance (45%) and epilepsy (~30–35%). Frontal horn cystic degeneration on MRI was reported in 45% of cases. EIF2B4 and EIF2B5 were highlighted among the more frequently implicated genes in this phenotype. (escobarpacheco2024ovarioleukodystrophydueto pages 1-2, escobarpacheco2024ovarioleukodystrophydueto pages 2-4, escobarpacheco2024ovarioleukodystrophydueto pages 8-10)
The same 2024 paper reports a new case with a homozygous EIF2B4 c.725C>T (p.Pro242Leu) variant, supporting direct EIF2B4 involvement in ovarioleukodystrophy/VWM-spectrum disease. (escobarpacheco2024ovarioleukodystrophydueto pages 2-4)
A 2023 cohort of 13 Chinese pediatric patients with genetic white matter disorders included EIF2B4 in 2 patients, and described a novel EIF2B4 splice-site variant c.885+2T>G. (dong2023genotypicandphenotypic pages 2-4)
Open Targets lists EIF2B4 associations with leukoencephalopathy with vanishing white matter, CACH syndrome, and ovarioleukodystrophy, providing a curated evidence complement to the primary literature (association scores and evidence counts are database metrics rather than case frequencies). (OpenTargets Search: -EIF2B4)
The available primary evidence supports cytoplasmic function, including localization to eIF2B bodies. In mammalian cells, eIF2B bodies are heterogeneous; larger bodies are more likely to include regulatory subunits such as δ, whereas smaller bodies are enriched for catalytic subunits, implying multiple functional pools of eIF2B complexes that may differ in GEF output and stress sensitivity. (hanson2024eif2blocalizationand pages 2-4, hanson2024eif2blocalizationand media e26945f7)
EIF2B’s biochemical role is GDP→GTP exchange on eIF2, and thus its functional “substrate” is eIF2 (GDP-bound after initiation); ISR regulation acts by converting phosphorylated eIF2 into an inhibitor of this exchange reaction. (hanson2024eif2blocalizationand pages 1-2, wek2023survivingandadapting pages 1-2)
EIF2B4/eIF2Bδ contributes to this pathway primarily through complex assembly/state regulation and inhibitory interactions rather than direct catalysis. (wortham2014analysisofthe pages 9-10, hanson2024eif2blocalizationand pages 1-2)
While most ISRIB literature treats eIF2B as a complex-level target, EIF2B4-specific pharmacology is supported by evidence that δ residues sit near allosteric ligand sites and that δ mutations can alter responses to eIF2B-targeting compounds. For example, an EIF2B4 L180F mutant background altered sensitivity to an eIF2B inhibitory compound series and abolished ISRIB-mediated reversal of its activity, demonstrating that δ can be a determinant of drug response at the complex interface. (shilliday2025amolecularstabiliser pages 11-14)
The following tables consolidate the key evidence:
| Aspect | Key points | Evidence (cite IDs) |
|---|---|---|
| Gene/protein identity | EIF2B4 encodes the human translation initiation factor eIF2B subunit delta (eIF2Bδ), corresponding to UniProt Q9UI10; it is a noncatalytic/regulatory component of the eIF2B complex in Homo sapiens. | (OpenTargets Search: -EIF2B4, wortham2014analysisofthe pages 9-10) |
| Role in eIF2B complex | eIF2B is a heterodecamer with two copies each of α, β, γ, δ, and ε. EIF2B4/eIF2Bδ belongs to the regulatory subunits (α/β/δ), contributes to holocomplex assembly, and participates in the β/δ core that supports formation of the active complex. | (hanson2023theroleof pages 38-42, wortham2014analysisofthe pages 9-10, ghahnavieh2024therapeuticpotentialof pages 34-38) |
| Structural/assembly role | Experimental MS, pulldown, and SEC studies support a structural role for δ in decamer assembly and inter-subcomplex organization; βδ-containing assemblies are lower-activity intermediates relative to the full holoenzyme. | (wortham2014analysisofthe pages 9-10, wortham2014analysisofthe pages 4-5, wortham2014analysisofthe pages 10-11) |
| Biochemical function of the complex | The eIF2B complex is the guanine nucleotide exchange factor (GEF) for eIF2, catalyzing GDP→GTP exchange to regenerate active eIF2-GTP for ternary complex formation and translation initiation. Catalytic activity resides mainly in γ/ε, while δ enhances full activity through regulation and assembly. | (hanson2023theroleof pages 38-42, hanson2024eif2blocalizationand pages 1-2, wek2023survivingandadapting pages 1-2) |
| ISR inhibition mechanism | During stress, eIF2α Ser51 phosphorylation converts eIF2 into an inhibitor of eIF2B. Structural/mechanistic summaries place phospho-eIF2α at an interface between eIF2B1 (α) and eIF2B4 (δ), which blocks productive engagement of eIF2γ with catalytic eIF2Bε, suppressing nucleotide exchange and global translation. | (ghahnavieh2024therapeuticpotentialof pages 34-38, hanson2024eif2blocalizationand pages 1-2, wek2023survivingandadapting pages 1-2) |
| Subcellular localization | eIF2B localizes in the cytoplasm in discrete eIF2B bodies, which are sites of GEF activity. In mammalian cells, small bodies are enriched for catalytic subunits, whereas large bodies more often contain all subunits and are consistent with decameric complexes. | (hanson2024eif2blocalizationand pages 2-4, hanson2024eif2blocalizationand pages 1-2, hanson2023theroleof pages 114-120, hanson2024eif2blocalizationand media e26945f7) |
| eIF2Bδ inclusion in bodies | Baseline eIF2Bδ inclusion is cell-type specific. Reported co-localization of δ with small bodies: SH-SY5Y 20.83%, U373 10.63%, MO3.13 9.03%; with large bodies: SH-SY5Y 62.39%, U373 67.48%, MO3.13 65.00%. Acute ER stress redistributes δ toward small bodies. | (hanson2024eif2blocalizationand pages 2-4, hanson2024eif2blocalizationand media e26945f7) |
| Isoforms | eIF2Bδ has at least long and short alternatively spliced isoforms. The long isoform is associated with attenuated ISR signaling and impaired binding to phospho-eIF2α, whereas the short isoform preserves stress-induced translational inhibition and is associated with stronger ISR marker induction. Complex integrity is retained. | (hanson2023theroleof pages 42-45) |
| Pathway context | EIF2B4 functions in the translation initiation pathway and the integrated stress response (ISR), where changes in eIF2B activity tune global protein synthesis and selective translation of stress-responsive mRNAs such as ATF4. | (hanson2023theroleof pages 38-42, hanson2024eif2blocalizationand pages 1-2, wek2023survivingandadapting pages 1-2) |
| Disease link | Pathogenic EIF2B4 variants are linked to vanishing white matter disease (VWM/CACH) and ovarioleukodystrophy. Open Targets lists associations with leukoencephalopathy with vanishing white matter, CACH syndrome, and ovarioleukodystrophy. | (OpenTargets Search: -EIF2B4, escobarpacheco2024ovarioleukodystrophydueto pages 1-2, escobarpacheco2024ovarioleukodystrophydueto pages 2-4) |
| Recent disease statistics relevant to EIF2B4 | A 2024 systematic review of EIF2B-related ovarioleukodystrophy compiled 20 cases worldwide, with median onset 19 years; ovarian presentations included premature ovarian failure (60%), secondary amenorrhea (15%), primary amenorrhea (15%), and ovarian dysgenesis (5%). EIF2B4 and EIF2B5 were highlighted among the more frequently implicated genes in this phenotype. | (escobarpacheco2024ovarioleukodystrophydueto pages 1-2, escobarpacheco2024ovarioleukodystrophydueto pages 2-4, escobarpacheco2024ovarioleukodystrophydueto pages 8-10) |
Table: This table summarizes the verified identity, molecular function, ISR mechanism, localization, isoform behavior, and disease relevance of human EIF2B4/eIF2Bδ. It is designed as a compact evidence map for functional annotation with direct context-ID citations.
| Citation (author, year) | Publication date/month | Venue | Main finding relevant to EIF2B4 | URL | Evidence IDs |
|---|---|---|---|---|---|
| Wek et al., 2023 | Aug 2023 | Antioxidants & Redox Signaling | Authoritative ISR review: eIF2B is the GEF for eIF2; phosphorylation of eIF2α inhibits eIF2B-mediated GDP→GTP exchange, lowering ternary-complex formation and reprogramming translation. While not EIF2B4-specific, it provides current consensus framework for the regulatory role of eIF2Bδ within ISR control. | https://doi.org/10.1089/ars.2022.0123 | (wek2023survivingandadapting pages 1-2, wek2023survivingandadapting pages 5-6) |
| Hanson et al., 2024 | Sep 2024 | iScience | Peer-reviewed cell-biology study showing eIF2B localizes to cytoplasmic eIF2B bodies with cell-type-specific composition; eIF2Bδ is present in both small and large bodies, and its redistribution changes with stress and ISRIB treatment, supporting a localization-dependent regulatory role for EIF2B4 in neurons and glia. | https://doi.org/10.1016/j.isci.2024.110851 | (hanson2024eif2blocalizationand pages 2-4, hanson2024eif2blocalizationand pages 1-2, hanson2024eif2blocalizationand media e26945f7) |
| Gupta et al., 2023 | Apr 2023 | Proceedings of the National Academy of Sciences of the USA (PNAS) | Demonstrates that overexpression of eIF2Bδ in breast cancer stem cells suppresses strong ISR induction through preferential interaction with phospho-eIF2α, sustaining eIF2B activity and promoting invasion/metastasis; identifies EIF2B4/eIF2Bδ as functionally important in cancer stress adaptation. | https://doi.org/10.1073/pnas.2207898120 | (gupta2023eif2bδblocksthe pages 1-2) |
| Escobar-Pacheco et al., 2024 | Jul 2024 | Cureus | Systematic review and case report on ovarioleukodystrophy due to EIF2B genes: 20 worldwide cases compiled, median onset 19 years, with missense variants predominating and EIF2B4/EIF2B5 notably represented; supports the clinical relevance of EIF2B4 in adult and adolescent VWM-spectrum disease. | https://doi.org/10.7759/cureus.64497 | (escobarpacheco2024ovarioleukodystrophydueto pages 1-2, escobarpacheco2024ovarioleukodystrophydueto pages 2-4, escobarpacheco2024ovarioleukodystrophydueto pages 8-10, escobarpacheco2024ovarioleukodystrophydueto pages 10-11) |
| Dong et al., 2023 | Nov 2023 | Italian Journal of Pediatrics | Pediatric white-matter-disorder cohort identifying EIF2B4 among causal genes, including a novel splice-site variant c.885+2T>G; supports ongoing discovery of pathogenic EIF2B4 alleles in leukodystrophy diagnostics. | https://doi.org/10.1186/s13052-023-01555-z | (dong2023genotypicandphenotypic pages 2-4) |
| Wortham et al., 2014 | May 2014 | The FASEB Journal | Foundational structural/biochemical study showing eIF2B is a heterodecamer and placing eIF2Bδ among the α/β/δ regulatory subunits that support decamer assembly and full holoenzyme function; provides key experimental basis for interpreting EIF2B4’s scaffold/regulatory role. | https://doi.org/10.1096/fj.13-243329 | (wortham2014analysisofthe pages 9-10, wortham2014analysisofthe pages 4-5, wortham2014analysisofthe pages 10-11, wortham2014analysisofthe pages 11-12) |
Table: This table summarizes core recent and foundational publications needed to interpret human EIF2B4/eIF2Bδ function, localization, ISR biology, and disease relevance. It is useful as a citation-ready literature map for the final research report.
| Phenotype | Gene(s) | Study (year) | Sample size | Key stats | Notes/limitations | URL | Evidence IDs |
|---|---|---|---|---|---|---|---|
| Ovarioleukodystrophy / vanishing white matter disease (aggregate review) | EIF2B1-5, with EIF2B4 and EIF2B5 frequently implicated by missense variants | Escobar-Pacheco et al. (2024) | 20 cases worldwide compiled from 14 reports | Median age at onset 19 years (range 0.6-40); ovarian manifestations: premature ovarian failure 60%, primary amenorrhea 15%, secondary amenorrhea 15%, ovarian dysgenesis 5%; neurologic findings included pyramidal/gait disturbance 45%, epilepsy ~30-35%; frontal horn cystic degeneration on MRI in 45% | Ultra-rare phenotype; statistics are aggregate across all EIF2B genes, not EIF2B4-only; small case numbers limit genotype-specific inference | https://doi.org/10.7759/cureus.64497 | (escobarpacheco2024ovarioleukodystrophydueto pages 1-2, escobarpacheco2024ovarioleukodystrophydueto pages 2-4, escobarpacheco2024ovarioleukodystrophydueto pages 8-10, escobarpacheco2024ovarioleukodystrophydueto pages 10-11) |
| Ovarioleukodystrophy case with explicit EIF2B4 variant | EIF2B4 | Escobar-Pacheco et al. (2024) | 1 new case within the above review | Homozygous EIF2B4 c.725C>T (p.Pro242Leu) identified by NGS; supports causal association of EIF2B4 with ovarioleukodystrophy/VWM spectrum | Single case; useful for gene-specific confirmation but not for prevalence estimation | https://doi.org/10.7759/cureus.64497 | (escobarpacheco2024ovarioleukodystrophydueto pages 2-4) |
| Pediatric genetic white matter disorders cohort | EIF2B3, EIF2B4, EIF2B5 among other genes | Dong et al. (2023) | 13 total patients | EIF2B4 represented in 2 patients; EIF2B3 n=2, EIF2B4 n=2, EIF2B5 n=2; EIF2B4 splice-site variant c.885+2T>G reported as novel; EIF2B-related cases showed bilateral white matter hyperintensities and cystic degeneration noted for EIF2B4/EIF2B5 carriers in the paper summary | Small single-center pediatric cohort; not specific to one phenotype and not designed for prevalence estimates | https://doi.org/10.1186/s13052-023-01555-z | (dong2023genotypicandphenotypic pages 2-4) |
| EIF2B4 disease-target association: leukoencephalopathy with vanishing white matter | EIF2B4 | Open Targets platform (accessed in current evidence context) | Association evidence size = 5 | Disease association reported for leukoencephalopathy with vanishing white matter, leukoencephalopathy with vanishing white matter 1, leukoencephalopathy with vanishing white matter 4, and CACH syndrome; highest listed aggregate score in returned set was 0.8301 for "leukoencephalopathy with vanishing white matter" | Platform-level association evidence, not a clinical cohort; evidence size/score are database metrics rather than patient counts | https://platform.opentargets.org | (OpenTargets Search: -EIF2B4) |
| EIF2B4 disease-target association: ovarioleukodystrophy | EIF2B4 | Open Targets platform (accessed in current evidence context) | Association evidence size = 5 | Association reported for ovarioleukodystrophy with score 0.6093 in returned results | Database evidence complements literature but does not provide phenotype frequency or natural-history statistics | https://platform.opentargets.org | (OpenTargets Search: -EIF2B4) |
Table: This table summarizes recent clinical and database evidence linking EIF2B4 to vanishing white matter disease and ovarioleukodystrophy, emphasizing available case counts, phenotype frequencies, and key limitations. It is useful for quickly separating aggregate EIF2B-family statistics from the more limited gene-specific evidence for EIF2B4.
| Modality/compound | Target/mechanism | Evidence of involvement of β/δ core or EIF2B4 | Application area | Development stage | Key quantitative data | URL | Evidence IDs |
|---|---|---|---|---|---|---|---|
| ISRIB | Small-molecule eIF2B activator; binds the symmetric interface of eIF2B and stabilizes the active A-state, making eIF2B GEF activity less sensitive to phospho-eIF2α and restoring translation | Directly engages the eIF2B β/δ interface and bridges opposing βδ-containing tetramers into higher-order octamer/decamer assemblies; described as acting through the β/δ core and as a site functionally linked to eIF2Bδ/EIF2B4 (ghahnavieh2024therapeuticpotentialof pages 34-38, hanson2023theroleof pages 45-50, gupta2023eif2bδblocksthe pages 1-2, wek2023survivingandadapting pages 5-6) | Preclinical cancer therapy; neuroprotection/cognitive rescue; VWM model rescue (ghahnavieh2024therapeuticpotentialof pages 34-38, hanson2023theroleof pages 45-50) | Preclinical research tool/drug lead | No single EC50 reported in the cited 2023–2024 summaries here; reported to promote octamer/decamer assembly and enhance GEF activity in lysates; efficacy depends on presence of ISR signaling/p-eIF2α in tumors (ghahnavieh2024therapeuticpotentialof pages 34-38, hanson2023theroleof pages 45-50) | https://doi.org/10.1073/pnas.2207898120 ; https://doi.org/10.1089/ars.2022.0123 | (ghahnavieh2024therapeuticpotentialof pages 34-38, hanson2023theroleof pages 45-50, gupta2023eif2bδblocksthe pages 1-2, wek2023survivingandadapting pages 5-6) |
| 2BAct | eIF2B activator identified with ISRIB-class molecules; blocks inhibitory phospho-eIF2 binding and functionally renders eIF2B more resistant to ISR suppression | Acts on eIF2B allosterically in the same therapeutic space as ISRIB; cited as an eIF2B activator with relevance to assembly/state control, though β/δ contact details are less explicit in the cited excerpts than for ISRIB (hanson2023theroleof pages 45-50, wek2023survivingandadapting pages 5-6) | VWMD/neuropathy and broader ISR-modulation applications (hanson2023theroleof pages 45-50, wek2023survivingandadapting pages 5-6) | Preclinical | In a VWMD mouse model carrying eIF2Bε R191H/R191H, 2BAct reversed neuropathology; no EC50 given in the cited excerpts (hanson2023theroleof pages 45-50) | https://doi.org/10.1089/ars.2022.0123 | (hanson2023theroleof pages 45-50, wek2023survivingandadapting pages 5-6) |
| ISRAC / Compound A-(S) | Small-molecule eIF2B inhibitor class that stabilizes the inactive I-state and promotes the inhibitory eIF2B–eIF2(αP) complex, thereby activating the ISR | Binds an overlapping regulatory pocket near eIF2Bδ L179 and eIF2Bβ N162; can bridge βγδε tetramers and favor the inhibitory conformation rather than the active one (shilliday2025amolecularstabiliser pages 11-14) | Chemical-biology tool; proposed opportunities in cancer sensitization, antiviral strategies, and protein-misfolding diseases (shilliday2025amolecularstabiliser pages 11-14, shilliday2025amolecularstabiliser pages 1-6) | Preclinical / preprint-stage discovery | Compound B (a related symmetric derivative) showed EC50 ~10 µM; enrichment/elimination in DEL screening depended on eIF2(αP) complex formation and ISRIB competition (shilliday2025amolecularstabiliser pages 11-14, shilliday2025amolecularstabiliser pages 1-6) | https://doi.org/10.1101/2025.09.25.678332 | (shilliday2025amolecularstabiliser pages 11-14, shilliday2025amolecularstabiliser pages 1-6) |
| ISRAC / Compound B | Symmetric derivative of Compound A-(S); attenuates eIF2B GEF activity and reduces translation by stabilizing the inhibitory eIF2B–eIF2(αP) state | Direct evidence for EIF2B4 involvement: effect mapped to the ISRIB/β-δ pocket neighborhood; EIF2B4 L180F mutant cells showed reduced sensitivity and lost ISRIB-mediated reversal, demonstrating δ-subunit-dependent pharmacology (shilliday2025amolecularstabiliser pages 11-14) | ISR activation as an experimental therapeutic strategy; proposed use in cancer combination therapy and antiviral/proteostasis settings (shilliday2025amolecularstabiliser pages 11-14) | Preclinical / preprint-stage discovery | EC50 ~10 µM overall; in EIF2B4 L180F mutant cells EC50 shifted from 15 µM to 22.63 µM; ISRIB reversal of Compound B action was lost in the mutant (shilliday2025amolecularstabiliser pages 11-14) | https://doi.org/10.1101/2025.09.25.678332 | (shilliday2025amolecularstabiliser pages 11-14) |
| eIF2Bδ overexpression axis in breast cancer stem cells | Not a drug itself, but a translationally relevant target state: elevated eIF2Bδ suppresses strong ISR induction by preferential interaction with phospho-eIF2α, sustaining eIF2B activity | Directly implicates EIF2B4/eIF2Bδ in metastasis biology and identifies δ as a functional site of ISRIB action in CSCs (gupta2023eif2bδblocksthe pages 1-2) | Breast cancer stem cell survival, invasion, metastasis (gupta2023eif2bδblocksthe pages 1-2) | Preclinical target validation | No EC50 reported; biological effect includes requirement of elevated eIF2Bδ for CSC expansion and metastasis in animal models (gupta2023eif2bδblocksthe pages 1-2) | https://doi.org/10.1073/pnas.2207898120 | (gupta2023eif2bδblocksthe pages 1-2) |
| NCT07272525 | Single-patient investigational treatment for Cree leukoencephalopathy/vanishing white matter disease | Real-world implementation relevant to EIF2B-pathies/VWM; trial listing indicates translational movement toward individualized intervention, though mechanism/intervention details are not provided in the retrieved excerpt (OpenTargets Search: -EIF2B4) | Cree leukoencephalopathy / VWM | Active, not recruiting; Early Phase 1; interventional | Enrollment: 1 participant (OpenTargets Search: -EIF2B4) | https://clinicaltrials.gov/study/NCT07272525 | (OpenTargets Search: -EIF2B4) |
| NCT07300397 | Single-patient investigational treatment for Cree leukoencephalopathy | Real-world implementation relevant to EIF2B-related white matter disease; retrieved clinical-trial summary supports existence of individualized translational efforts, but no β/δ-core mechanistic detail is available in the excerpt (OpenTargets Search: -EIF2B4) | Cree leukoencephalopathy / VWM-related disease context | Active, not recruiting; interventional | Enrollment: 1 participant (OpenTargets Search: -EIF2B4) | https://clinicaltrials.gov/study/NCT07300397 | (OpenTargets Search: -EIF2B4) |
Table: This table summarizes translational and real-world applications of eIF2B/ISR modulation relevant to EIF2B4, including activators, ISR-activating compounds, and individualized clinical-trial efforts in VWM-related disease. It highlights where the β/δ core or EIF2B4 specifically informs mechanism, drug response, and disease relevance.
References
(wortham2014analysisofthe pages 9-10): Noel C. Wortham, Magdalena Martinez, Yuliya Gordiyenko, Carol V. Robinson, and Christopher G. Proud. Analysis of the subunit organization of the eif2b complex reveals new insights into its structure and regulation. The FASEB Journal, 28:2225-2237, May 2014. URL: https://doi.org/10.1096/fj.13-243329, doi:10.1096/fj.13-243329. This article has 82 citations.
(hanson2024eif2blocalizationand pages 1-2): Filipe M. Hanson, Madalena I. Ribeiro de Oliveira, Alison K. Cross, K. Elizabeth Allen, and Susan G. Campbell. Eif2b localization and its regulation during the integrated stress response is cell-type specific. Sep 2024. URL: https://doi.org/10.1016/j.isci.2024.110851, doi:10.1016/j.isci.2024.110851. This article has 6 citations and is from a peer-reviewed journal.
(wek2023survivingandadapting pages 1-2): Ronald C. Wek, Tracy G. Anthony, and Kirk A. Staschke. Surviving and adapting to stress: translational control and the integrated stress response. Antioxidants & Redox Signaling, 39:351-373, Aug 2023. URL: https://doi.org/10.1089/ars.2022.0123, doi:10.1089/ars.2022.0123. This article has 87 citations and is from a domain leading peer-reviewed journal.
(hanson2023theroleof pages 38-42): FM da Silva Hanson. The role of eif2b localisation in cell-specific stress responses. ArXiv, 2023. URL: https://doi.org/10.7190/shu-thesis-00555, doi:10.7190/shu-thesis-00555. This article has 0 citations.
(ghahnavieh2024therapeuticpotentialof pages 34-38): L Ebrahimi Ghahnavieh. Therapeutic potential of targeting eukaryotic translation initiation factor (eif2b) in mutant kras lung cancer. Unknown journal, 2024.
(wortham2014analysisofthe pages 4-5): Noel C. Wortham, Magdalena Martinez, Yuliya Gordiyenko, Carol V. Robinson, and Christopher G. Proud. Analysis of the subunit organization of the eif2b complex reveals new insights into its structure and regulation. The FASEB Journal, 28:2225-2237, May 2014. URL: https://doi.org/10.1096/fj.13-243329, doi:10.1096/fj.13-243329. This article has 82 citations.
(hanson2023theroleof pages 45-50): FM da Silva Hanson. The role of eif2b localisation in cell-specific stress responses. ArXiv, 2023. URL: https://doi.org/10.7190/shu-thesis-00555, doi:10.7190/shu-thesis-00555. This article has 0 citations.
(hanson2024eif2blocalizationand pages 2-4): Filipe M. Hanson, Madalena I. Ribeiro de Oliveira, Alison K. Cross, K. Elizabeth Allen, and Susan G. Campbell. Eif2b localization and its regulation during the integrated stress response is cell-type specific. Sep 2024. URL: https://doi.org/10.1016/j.isci.2024.110851, doi:10.1016/j.isci.2024.110851. This article has 6 citations and is from a peer-reviewed journal.
(hanson2024eif2blocalizationand media e26945f7): Filipe M. Hanson, Madalena I. Ribeiro de Oliveira, Alison K. Cross, K. Elizabeth Allen, and Susan G. Campbell. Eif2b localization and its regulation during the integrated stress response is cell-type specific. Sep 2024. URL: https://doi.org/10.1016/j.isci.2024.110851, doi:10.1016/j.isci.2024.110851. This article has 6 citations and is from a peer-reviewed journal.
(gupta2023eif2bδblocksthe pages 1-2): Malavika Gupta, Beth A. Walters, Olga Katsara, Karol Granados Blanco, Phillip A. Geter, and Robert J. Schneider. Eif2bδ blocks the integrated stress response and maintains eif2b activity and cancer metastasis by overexpression in breast cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America, Apr 2023. URL: https://doi.org/10.1073/pnas.2207898120, doi:10.1073/pnas.2207898120. This article has 15 citations and is from a highest quality peer-reviewed journal.
(dong2023genotypicandphenotypic pages 2-4): Liling Dong, Li Shang, Caiyan Liu, Chenhui Mao, Xinying Huang, Shanshan Chu, Bin Peng, Liying Cui, and Jing Gao. Genotypic and phenotypic heterogeneity among chinese pediatric genetic white matter disorders. Italian Journal of Pediatrics, Nov 2023. URL: https://doi.org/10.1186/s13052-023-01555-z, doi:10.1186/s13052-023-01555-z. This article has 2 citations and is from a peer-reviewed journal.
(wek2023survivingandadapting pages 5-6): Ronald C. Wek, Tracy G. Anthony, and Kirk A. Staschke. Surviving and adapting to stress: translational control and the integrated stress response. Antioxidants & Redox Signaling, 39:351-373, Aug 2023. URL: https://doi.org/10.1089/ars.2022.0123, doi:10.1089/ars.2022.0123. This article has 87 citations and is from a domain leading peer-reviewed journal.
(OpenTargets Search: -EIF2B4): Open Targets Query (-EIF2B4, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(escobarpacheco2024ovarioleukodystrophydueto pages 1-2): Mariana Escobar-Pacheco, Mariana Luna-Álvarez, David Dávila-Ortiz de Montellano, Petra Yescas-Gómez, and Miguel Á Ramírez-García. Ovarioleukodystrophy due to eif2b genes: systematic review and case report. Cureus, Jul 2024. URL: https://doi.org/10.7759/cureus.64497, doi:10.7759/cureus.64497. This article has 4 citations.
(escobarpacheco2024ovarioleukodystrophydueto pages 2-4): Mariana Escobar-Pacheco, Mariana Luna-Álvarez, David Dávila-Ortiz de Montellano, Petra Yescas-Gómez, and Miguel Á Ramírez-García. Ovarioleukodystrophy due to eif2b genes: systematic review and case report. Cureus, Jul 2024. URL: https://doi.org/10.7759/cureus.64497, doi:10.7759/cureus.64497. This article has 4 citations.
(escobarpacheco2024ovarioleukodystrophydueto pages 8-10): Mariana Escobar-Pacheco, Mariana Luna-Álvarez, David Dávila-Ortiz de Montellano, Petra Yescas-Gómez, and Miguel Á Ramírez-García. Ovarioleukodystrophy due to eif2b genes: systematic review and case report. Cureus, Jul 2024. URL: https://doi.org/10.7759/cureus.64497, doi:10.7759/cureus.64497. This article has 4 citations.
(shilliday2025amolecularstabiliser pages 11-14): Fiona Shilliday, Miguel Gancedo-Rodrigo, Ginto George, Santosh Adhikari, Syedah Neha Ashraf, Evelyne J. C. Barrey, Paolo A. Centrella, Damian Crowther, Paige Dickson, Diana Gikunju, Marie-Aude Guié, John P. Guilinger, Anders Gunnarsson, Heather P. Harding, Christopher D. Hupp, Rachael Jetson, Anthony D. Keefe, JeeSoo Monica Kim, Richard J. Lewis, Taiana Maia de Oliveira, Jennifer Le-Marshall, Usha Narayanan, Katherine A. Nugai, Dušan Petrović, Emma Rivers, David Ron, Daisy Stringfellow, Karl Syson, Lewis Ward, John T. S. Yeoman, Yan Yu, Ying Zhang, Alisa Zyryanova, David Baker, Perla Breccia, and John Linley. A molecular stabiliser of an inhibitory eif2b-eif2(αp) complex activates the integrated stress response. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.25.678332, doi:10.1101/2025.09.25.678332. This article has 1 citations.
(wortham2014analysisofthe pages 10-11): Noel C. Wortham, Magdalena Martinez, Yuliya Gordiyenko, Carol V. Robinson, and Christopher G. Proud. Analysis of the subunit organization of the eif2b complex reveals new insights into its structure and regulation. The FASEB Journal, 28:2225-2237, May 2014. URL: https://doi.org/10.1096/fj.13-243329, doi:10.1096/fj.13-243329. This article has 82 citations.
(hanson2023theroleof pages 114-120): FM da Silva Hanson. The role of eif2b localisation in cell-specific stress responses. ArXiv, 2023. URL: https://doi.org/10.7190/shu-thesis-00555, doi:10.7190/shu-thesis-00555. This article has 0 citations.
(hanson2023theroleof pages 42-45): FM da Silva Hanson. The role of eif2b localisation in cell-specific stress responses. ArXiv, 2023. URL: https://doi.org/10.7190/shu-thesis-00555, doi:10.7190/shu-thesis-00555. This article has 0 citations.
(escobarpacheco2024ovarioleukodystrophydueto pages 10-11): Mariana Escobar-Pacheco, Mariana Luna-Álvarez, David Dávila-Ortiz de Montellano, Petra Yescas-Gómez, and Miguel Á Ramírez-García. Ovarioleukodystrophy due to eif2b genes: systematic review and case report. Cureus, Jul 2024. URL: https://doi.org/10.7759/cureus.64497, doi:10.7759/cureus.64497. This article has 4 citations.
(wortham2014analysisofthe pages 11-12): Noel C. Wortham, Magdalena Martinez, Yuliya Gordiyenko, Carol V. Robinson, and Christopher G. Proud. Analysis of the subunit organization of the eif2b complex reveals new insights into its structure and regulation. The FASEB Journal, 28:2225-2237, May 2014. URL: https://doi.org/10.1096/fj.13-243329, doi:10.1096/fj.13-243329. This article has 82 citations.
(shilliday2025amolecularstabiliser pages 1-6): Fiona Shilliday, Miguel Gancedo-Rodrigo, Ginto George, Santosh Adhikari, Syedah Neha Ashraf, Evelyne J. C. Barrey, Paolo A. Centrella, Damian Crowther, Paige Dickson, Diana Gikunju, Marie-Aude Guié, John P. Guilinger, Anders Gunnarsson, Heather P. Harding, Christopher D. Hupp, Rachael Jetson, Anthony D. Keefe, JeeSoo Monica Kim, Richard J. Lewis, Taiana Maia de Oliveira, Jennifer Le-Marshall, Usha Narayanan, Katherine A. Nugai, Dušan Petrović, Emma Rivers, David Ron, Daisy Stringfellow, Karl Syson, Lewis Ward, John T. S. Yeoman, Yan Yu, Ying Zhang, Alisa Zyryanova, David Baker, Perla Breccia, and John Linley. A molecular stabiliser of an inhibitory eif2b-eif2(αp) complex activates the integrated stress response. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.25.678332, doi:10.1101/2025.09.25.678332. This article has 1 citations.

Gene and Complex Overview:
EIF2B4 encodes the δ subunit of eukaryotic initiation factor 2B (eIF2B), a multi-subunit guanine nucleotide exchange factor essential for protein synthesis (www.ncbi.nlm.nih.gov). The eIF2B complex is composed of five different subunits (α, β, γ, δ, ε), present as two copies each in a twofold-symmetric decamer (pmc.ncbi.nlm.nih.gov). This heterodecameric assembly consists of two βδεγ tetramers bridged by an α₂ homodimer (pmc.ncbi.nlm.nih.gov), yielding a ~600 kDa complex. The δ subunit (EIF2B4) together with the α and β subunits forms a regulatory subcomplex that senses cellular stress signals, while the γ and ε subunits constitute the catalytic core responsible for nucleotide exchange (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Notably, evolutionary analyses suggest the γ₂ε₂ catalytic core arose first, with the regulatory subunits like δ added later to fine-tune eIF2B’s control of translation (pmc.ncbi.nlm.nih.gov). By assembling these subunits, eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis (pmc.ncbi.nlm.nih.gov). Proper regulation of this complex is vital for cells to adjust protein production to changing conditions and stresses (learn.mapmygenome.in).
Primary Function – GEF Activity in Translation Initiation:
The primary function of eIF2B (and thus EIF2B4 as part of it) is to reactivate the translation initiator factor eIF2 by catalyzing the exchange of GDP for GTP on eIF2’s γ subunit (learn.mapmygenome.in). During translation initiation, eIF2·GTP binds initiator methionine-tRNA and delivers it to the 40S ribosome; GTP is hydrolyzed upon start-codon recognition, and eIF2-GDP is released (pmc.ncbi.nlm.nih.gov). eIF2B then displaces the GDP-bound inhibitor (eIF5) from eIF2-GDP and catalyzes GDP release so a new GTP can bind, “recharging” eIF2 for another round of initiation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Structural studies show that eIF2Bε (catalytic subunit) and eIF2Bγ engage eIF2γ in a way that pries open the nucleotide-binding site of eIF2, stabilizing an empty (apo) state to promote nucleotide exchange (pmc.ncbi.nlm.nih.gov). In this manner, eIF2B acts as a classic GEF: it converts inactive eIF2-GDP into active eIF2-GTP, which is necessary for maintaining overall protein synthesis. Quantitatively, the fully assembled eIF2B decamer has >20-fold higher nucleotide exchange activity than partial subcomplexes (pmc.ncbi.nlm.nih.gov), emphasizing that all subunits (including δ) are required for maximal function. The tight coupling of eIF2B’s activity to the translation cycle is critical – if eIF2B function is impaired, eIF2 remains GDP-bound and global translation initiation is impeded. Consistent with this, mutations in EIF2B4 that reduce eIF2B’s GEF activity cause severe translational defects, as seen in the genetic disorder vanishing white matter disease (medlineplus.gov).
Regulation via the Integrated Stress Response (ISR):
eIF2B4’s role is especially important in the integrated stress response, a conserved signaling pathway that downregulates protein synthesis under stress. In response to various stresses (e.g. nutrient starvation, viral infection, ER stress), specialized kinases such as PKR, GCN2, PERK, and HRI phosphorylate eIF2 on its α subunit at Ser51 (pmc.ncbi.nlm.nih.gov). Phosphorylation converts eIF2 from a substrate into a competitive inhibitor of eIF2B (pmc.ncbi.nlm.nih.gov). Mechanistically, unphosphorylated eIF2 binds productively to eIF2B at multiple interfaces (contacting eIF2Bβ and eIF2Bδ among others) to permit GDP–GTP exchange (pmc.ncbi.nlm.nih.gov). However, phosphorylated eIF2 (eIF2α-P) binds eIF2B in an alternative mode: the N-terminal region of eIF2α-P docks at the interface between the eIF2Bα and δ subunits (pmc.ncbi.nlm.nih.gov). This interaction locks eIF2B in a “nonproductive” conformation that prevents it from catalyzing nucleotide exchange on other eIF2 molecules (pmc.ncbi.nlm.nih.gov). In essence, eIF2B becomes sequestered in an inactive eIF2α-P•eIF2B complex, and cannot recycle GTP for the pool of eIF2. Functionally, this leads to a rapid reduction in global translation initiation, helping cells conserve resources and reprogram gene expression under stress (pmc.ncbi.nlm.nih.gov). As an NIH summary explains, under normal conditions eIF2B increases protein synthesis by GTP recycling, whereas under stress, eIF2B binds tightly to phospho-eIF2 and is rendered inactive, stalling further GTP recycling (medlineplus.gov). This switch is the core of the ISR: general protein synthesis is suppressed while specific stress-responsive mRNAs are selectively translated (e.g. ATF4) to adapt to the stress (pmc.ncbi.nlm.nih.gov). The δ subunit (EIF2B4) is central to this regulation, since along with α and β it forms the binding interface for eIF2α-P (pmc.ncbi.nlm.nih.gov). Experimental evidence from yeast and human cells shows that mutations in the regulatory subunits (including δ) can abolish eIF2α-P binding and render eIF2B insensitive to stress signals (pmc.ncbi.nlm.nih.gov). Indeed, a recent 2023 structural study confirmed that eIF2α-P engages a specific cavity spanning eIF2Bα and δ, and if this interaction is blocked, eIF2B stays active despite eIF2 phosphorylation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Intriguingly, several viruses have evolved proteins to exploit this: viral “ISR antagonists” can occupy the eIF2α-P binding site on eIF2Bδ/α, preventing the inhibitory switch and allowing viral mRNA translation to continue even when the host cell triggers PKR and eIF2α phosphorylation (pmc.ncbi.nlm.nih.gov). This underscores how pivotal EIF2B4’s function is – both cellular stress responses and pathogens target the eIF2Bδ interface to control protein synthesis.
Subcellular Localization and eIF2B Bodies:
The EIF2B4 gene product (eIF2Bδ) carries out its function in the cytosol, where translation initiation occurs. Early cell biology studies indicated eIF2B is largely a cytosolic complex, not concentrated in organelles or the nucleus. More recently, live-cell imaging has shown that eIF2B subunits assemble into distinct cytoplasmic foci known as “eIF2B bodies.” In human cells, fluorescent-tagged eIF2B subunits revealed that eIF2B is not diffused uniformly but clusters in a few cytoplasmic puncta (pubmed.ncbi.nlm.nih.gov). Larger eIF2B bodies contain all five subunits of the decameric complex, whereas smaller bodies often contain predominantly the γ and ε (catalytic) subunits (pubmed.ncbi.nlm.nih.gov). These bodies appear to be functional sites of action: the translation factor eIF2 itself localizes to eIF2B bodies and shuttles in and out of them in correlation with active nucleotide exchange (pubmed.ncbi.nlm.nih.gov). Under stress conditions, phosphorylated eIF2α concentrates in the larger eIF2B bodies, which coincides with a decrease in eIF2 mobility – essentially trapping eIF2 in inactive complexes (pubmed.ncbi.nlm.nih.gov). Interestingly, during acute stress the composition of smaller bodies can change, with eIF2Bδ (and other regulatory subunits) redistributing to them, suggesting the assembly state of eIF2B shifts in response to stress (pubmed.ncbi.nlm.nih.gov). This dynamic localization is thought to modulate eIF2B activity: active eIF2B may operate in smaller complexes or diffuse form when translation is robust, whereas upon stress, eIF2B gathers into larger assemblies that hold phospho-eIF2α, thereby spatially segregating the inhibited complexes (pubmed.ncbi.nlm.nih.gov). Similar eIF2B bodies have been observed in yeast, where a single large focus (sometimes a filamentous assembly) contains all eIF2B subunits (pmc.ncbi.nlm.nih.gov). The conservation of this phenomenon suggests that clustering of eIF2B is functionally relevant, possibly to efficiently coordinate the exchange cycle or to integrate stress signals. In summary, EIF2B4’s protein product is cytoplasmic and often localized in specialized subcellular structures (eIF2B bodies) where it carries out and regulates its GEF function.
Biological Pathways and Interactions:
EIF2B4/eIF2Bδ functions within the core translation initiation pathway. By recycling eIF2-GDP to eIF2-GTP, eIF2B enables continuous rounds of translation initiation – a process diagrammed in standard models of the translation cycle (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This places eIF2B at a critical node in proteostasis regulation. The integrated stress response (ISR) is the chief signaling pathway that modulates eIF2B’s activity via eIF2α phosphorylation, as discussed. Beyond the ISR, growth factor and metabolic signaling also impinge on eIF2B. For example, insulin – through the PI3K/Akt pathway – activates eIF2B by inhibiting GSK-3 kinase. GSK-3 can phosphorylate the eIF2Bε subunit at Ser535, which diminishes eIF2B’s activity; insulin signaling blocks GSK-3, leading to Ser535 dephosphorylation and enhanced eIF2B function (pmc.ncbi.nlm.nih.gov). Thus, in insulin-responsive tissues, eIF2B serves as a point of crosstalk between nutrient/growth signals and the protein synthesis machinery. This regulation ensures that in fed conditions (high insulin) eIF2B is maximally active to promote protein synthesis, whereas in energy stress or diabetes (high GSK-3 activity) eIF2B may be less active, contributing to reduced protein synthesis capacity (pmc.ncbi.nlm.nih.gov). EIF2B4, as part of the regulatory holoenzyme, is required for these modulation effects – studies in cell and animal models have shown that altering eIF2B4 levels or mutating its critical residues can affect how eIF2B responds to both stress and insulin signaling (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
Physiological and Real-World Significance:
The precise function of EIF2B4 in the eIF2B complex is underscored by its importance in human health and disease. Loss-of-function mutations in EIF2B4 (and other eIF2B subunit genes) cause Leukoencephalopathy with Vanishing White Matter (VWM), a fatal neurodegenerative disease (www.ncbi.nlm.nih.gov). VWM patients’ cells have partially impaired eIF2B activity, making them unable to properly resume protein synthesis after stress, particularly in oligodendrocytes and astrocytes that support white matter (medlineplus.gov). This leads to chronic white-matter degeneration provoked by minor stresses (fever, head trauma, etc.), highlighting how crucial eIF2B’s stress-regulatory function is in vivo (medlineplus.gov). The δ subunit is one of the genetic loci for VWM (VWM type 4), and dozens of EIF2B4 missense mutations have been documented in patients (www.ncbi.nlm.nih.gov). These mutations often map to surfaces involved in eIF2 or other subunit interactions, consistent with destabilizing the complex or disrupting eIF2α-P binding. Aside from rare genetic disorders, eIF2B (and thus EIF2B4) has attracted interest in common conditions as well. Neurological functions like memory formation rely on regulated protein synthesis, and studies in mice show that dysregulation of the eIF2/eIF2B axis can impair synaptic plasticity and memory (pmc.ncbi.nlm.nih.gov). Conversely, reducing excessive eIF2α phosphorylation (to boost eIF2B activity) can enhance memory in neurodegenerative or depressive models (pmc.ncbi.nlm.nih.gov). For instance, the small molecule ISRIB (Integrated Stress Response Inhibitor) binds eIF2B and allosterically promotes its active conformation, even in the presence of eIF2α-P (pmc.ncbi.nlm.nih.gov). ISRIB essentially antagonizes the inhibitory effect of phospho-eIF2 and reactivates translation, a discovery that has led to exploration of eIF2B activators in traumatic brain injury, cognitive decline, and other conditions (pmc.ncbi.nlm.nih.gov). A derivative compound called 2BAct has also shown therapeutic benefits in mouse models of vanishing white matter disease by enhancing eIF2B GEF activity (pmc.ncbi.nlm.nih.gov). These developments demonstrate real-world applications of our understanding of EIF2B4/eIF2B function: from diagnostic assays that measure eIF2B’s GEF activity in patient cells (pmc.ncbi.nlm.nih.gov), to targeted drugs aiming to modulate eIF2B for treating disease.
Conclusion:
In summary, EIF2B4 encodes the δ subunit of eIF2B, an essential enzyme complex governing the rate of translation initiation. EIF2B4’s product is a part of the regulatory scaffold that controls when eIF2B is active or inhibited, by sensing signals like eIF2’s phosphorylation state. Through its participation in eIF2B’s GTP-exchange reaction, EIF2B4 helps maintain the balance between active protein synthesis and translational shutdown during stress. This gene’s function is carried out in the cytosol, often localized to eIF2B-body structures where it interacts with eIF2. The current understanding – fortified by high-resolution structures (2018–2023) and mechanistic studies – is that eIF2Bδ (EIF2B4) is indispensable for coupling signaling pathways to the translational apparatus (pmc.ncbi.nlm.nih.gov) (medlineplus.gov). Its precise role in the eIF2B complex exemplifies how cells globally regulate protein synthesis, and disruptions of EIF2B4 vividly illustrate the consequences of losing that regulation. Ongoing research continues to uncover how this translation-initiation factor can be targeted or tuned in various physiological and disease contexts, reaffirming EIF2B4’s importance in cellular homeostasis and stress adaptation.
id: Q9UI10
gene_symbol: EIF2B4
product_type: PROTEIN
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
EIF2B4 encodes the delta subunit of eukaryotic translation initiation factor 2B (eIF2B),
a heterodecameric guanine nucleotide exchange factor (GEF) essential for translation initiation.
The delta subunit, together with alpha and beta subunits, forms the regulatory subcomplex that
senses cellular stress signals, particularly through binding phosphorylated eIF2alpha. The
eIF2B complex catalyzes GDP-GTP exchange on eIF2, regenerating active eIF2-GTP complexes
required for continued protein synthesis. EIF2B4 is critical for the integrated stress response
(ISR), where phosphorylated eIF2alpha binds at the interface between eIF2Balpha and eIF2Bdelta
subunits, inhibiting GEF activity and reducing global translation. eIF2Bdelta is a regulatory/scaffold
(noncatalytic) subunit that contributes to decameric holoenzyme assembly and is part of the
beta/delta core that supports allosteric regulation by small molecules such as ISRIB. In mammalian
cells, eIF2B (including the delta subunit) localizes to discrete cytoplasmic "eIF2B bodies"
whose subunit composition is cell-type specific and which represent sites of GEF activity
(PMID:39310746). Mutations in EIF2B4 cause vanishing white matter disease (leukoencephalopathy
with VWM) and ovarioleukodystrophy, demonstrating the essential role of this subunit in normal
eIF2B function, particularly in oligodendrocytes and astrocytes.
existing_annotations:
- term:
id: GO:0002183
label: cytoplasmic translational initiation
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
EIF2B4 is part of the eIF2B complex that functions in the cytoplasm to catalyze
GDP-GTP exchange on eIF2, which is essential for cytoplasmic translation initiation.
This annotation is well-supported by phylogenetic analysis and the deep research
showing eIF2B is a cytosolic complex essential for translation initiation [PMID:11323413].
action: ACCEPT
reason: >-
The IBA annotation is appropriate. EIF2B4 is a component of the eIF2B complex, which
is the sole GEF for eIF2 and is required for cytoplasmic translation initiation.
The deep research confirms "eIF2B serves as the sole guanine nucleotide exchange factor
(GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis."
supported_by:
- reference_id: PMID:11323413
supporting_text: "Initiation factor eIF2B mediates a key regulatory step in the initiation of mRNA translation, i.e. the regeneration of active eIF2.GTP complexes."
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-openai.md
supporting_text: "eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis"
- term:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
EIF2B4 encodes the delta subunit of the eIF2B complex, which is a heterodecameric
assembly. The delta subunit is part of the regulatory subcomplex along with alpha
and beta subunits. Cryo-EM structures have confirmed the architecture of the
complex [PMID:29599213].
action: ACCEPT
reason: >-
The delta subunit is a core component of the eIF2B complex. UniProt confirms
"Component of the translation initiation factor 2B (eIF2B) complex which is a
heterodecamer of two sets of five different subunits: alpha, beta, gamma, delta
and epsilon."
supported_by:
- reference_id: PMID:29599213
supporting_text: "Formation of fully active, decameric eIF2B holoenzyme depended on the assembly of two identical tetrameric subcomplexes"
- reference_id: PMID:11323413
supporting_text: "It is composed of five subunits, alpha-epsilon."
- reference_id: PMID:24532666
supporting_text: "Analysis of the subunit organization of the eIF2B complex reveals new insights into its structure and regulation"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
supporting_text: "eIF2B is a decamer composed of two copies of each of five subunits (α–ε) and place δ (EIF2B4) among the regulatory subunits (α/β/δ) rather than the catalytic subunits (γ/ε)"
- term:
id: GO:0003743
label: translation initiation factor activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
This IEA annotation from UniProtKB keyword mapping is appropriate as EIF2B4 is
part of eIF2B, which functions as a translation initiation factor by regenerating
active eIF2-GTP complexes needed for translation initiation [PMID:16289705].
action: ACCEPT
reason: >-
EIF2B4 as part of the eIF2B complex contributes to translation initiation factor
activity. PMID:16289705 demonstrates that "eIF2 and eIF2B augmented translation"
in cell-free systems, confirming the translation initiation factor activity.
Note that EIF2B4 itself does not have direct catalytic activity (catalytic core
is in epsilon/gamma subunits) but contributes to the overall activity of the complex.
supported_by:
- reference_id: PMID:16289705
supporting_text: "eIF2 (eukaryotic translation initiation factor 2) and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs."
- term:
id: GO:0005085
label: guanyl-nucleotide exchange factor activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
The eIF2B complex has GEF activity, catalyzing GDP-GTP exchange on eIF2.
While the catalytic activity resides primarily in the epsilon subunit, the
delta subunit is required for full GEF activity as part of the regulatory
subcomplex.
action: ACCEPT
reason: >-
The IEA annotation correctly identifies that the eIF2B complex has GEF activity.
PMID:11323413 directly characterizes "the mammalian initiation factor eIF2B complex
as a GDP dissociation stimulator protein." The delta subunit contributes to
this activity as part of the holoenzyme.
supported_by:
- reference_id: PMID:11323413
supporting_text: "mammalian eIF2B can mediate release of eIF2-bound GDP even in the absence of free nucleotide, indicating that it acts as a GDP dissociation stimulator protein"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
supporting_text: "eIF2B is the GEF for eIF2, recycling inactive eIF2–GDP to active eIF2–GTP, thereby replenishing the pool of eIF2 needed to form the ternary complex (eIF2–GTP·Met-tRNAi) and initiate translation"
- term:
id: GO:0005829
label: cytosol
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
EIF2B4 localizes to the cytosol as part of the eIF2B complex, where translation
initiation occurs. Deep research confirms "The EIF2B4 gene product (eIF2Bdelta)
carries out its function in the cytosol, where translation initiation occurs."
Recent work shows eIF2B localizes to discrete cytoplasmic eIF2B bodies (sites of
GEF activity) with cell-type-specific composition including the delta subunit
(PMID:39310746).
action: ACCEPT
reason: >-
The cytosolic localization is well-established for eIF2B subunits. UniProt
annotation states "Cytoplasm, cytosol" with ECO:0000250 evidence from S. pombe
ortholog. This is consistent with the function in cytoplasmic translation initiation.
supported_by:
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-openai.md
supporting_text: "The EIF2B4 gene product (eIF2Bdelta) carries out its function in the cytosol, where translation initiation occurs."
- reference_id: PMID:39310746
supporting_text: "eIF2B localization and its regulation during the integrated stress response is cell-type specific"
- term:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
Duplicate annotation (different evidence source from IBA above) confirming
EIF2B4 as a component of the eIF2B complex.
action: ACCEPT
reason: >-
This IEA annotation reinforces that EIF2B4 is part of the eIF2B complex.
Multiple evidence lines supporting the same conclusion is appropriate.
supported_by:
- reference_id: PMID:29599213
supporting_text: "Formation of fully active, decameric eIF2B holoenzyme depended on the assembly of two identical tetrameric subcomplexes"
- term:
id: GO:0006412
label: translation
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
EIF2B4 is involved in translation as part of the eIF2B complex, which is
essential for regenerating active eIF2-GTP complexes required for translation
initiation.
action: ACCEPT
reason: >-
The involvement in translation is well-established. The deep research states
"eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2,
playing a pivotal role in recycling eIF2 for continued protein synthesis."
GO:0006413 (translational initiation) would be more specific, but this parent
term is also accurate.
supported_by:
- reference_id: PMID:16289705
supporting_text: "eIF2 (eukaryotic translation initiation factor 2) and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs."
- term:
id: GO:0006413
label: translational initiation
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
EIF2B4 is involved in translational initiation as part of the eIF2B complex,
which regenerates eIF2-GTP needed for initiating translation of mRNAs.
action: ACCEPT
reason: >-
The role in translational initiation is directly supported by literature.
PMID:11323413 states "Initiation factor eIF2B mediates a key regulatory step
in the initiation of mRNA translation."
supported_by:
- reference_id: PMID:11323413
supporting_text: "Initiation factor eIF2B mediates a key regulatory step in the initiation of mRNA translation, i.e. the regeneration of active eIF2.GTP complexes."
- term:
id: GO:0007417
label: central nervous system development
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
This annotation is derived from ARBA machine learning. While EIF2B4 mutations
cause vanishing white matter disease affecting the CNS, the role of EIF2B4 in
CNS development is indirect - through its essential role in translation rather
than a specific developmental function.
action: KEEP_AS_NON_CORE
reason: >-
EIF2B4 is essential for protein synthesis, which is required for all developmental
processes. The CNS is particularly sensitive to EIF2B deficiency as shown in VWM
disease, but this reflects the high protein synthesis demands of oligodendrocytes
rather than a specific developmental role. This is a pleiotropic/secondary effect
rather than a core function.
supported_by:
- reference_id: PMID:15217090
supporting_text: "Vanishing white matter disease (VWM) is a progressive cavitating disease of central white matter due to a deficiency of the translation initiation factor eIF2B."
- term:
id: GO:0048513
label: animal organ development
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
This IEA annotation is too general and reflects the essential nature of
protein synthesis (requiring eIF2B) for all developmental processes rather
than a specific function of EIF2B4.
action: REMOVE
reason: >-
This is an over-annotation. EIF2B4 is essential for global protein synthesis,
which is required for all cellular processes including organ development.
However, there is no evidence that EIF2B4 plays a specific role in organ
development beyond enabling general translation. The annotation is too broad
and not informative for this gene.
supported_by:
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-openai.md
supporting_text: "eIF2B serves as the sole guanine nucleotide exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2 for continued protein synthesis"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
review:
summary: >-
Generic protein binding annotation from high-throughput interactome mapping.
EIF2B4 binds to EIF2B2 as part of the eIF2B complex.
action: REMOVE
reason: >-
GO curation guidelines discourage use of the generic "protein binding" term
when more specific terms are available. The interaction with EIF2B2 is better
captured by the eIF2B complex membership annotation (GO:0005851). More specific
terms like "translation initiation factor binding" (GO:0031369) are also annotated.
supported_by:
- reference_id: PMID:25416956
supporting_text: "A proteome-scale map of the human interactome network"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25910212
review:
summary: >-
High-throughput interaction study showing EIF2B4 interacts with EIF2B2.
action: REMOVE
reason: >-
The generic "protein binding" term is not informative. The interaction between
EIF2B4 and EIF2B2 is well-characterized as part of the eIF2B complex structure.
This is better represented by the complex membership annotation.
supported_by:
- reference_id: PMID:25910212
supporting_text: "Widespread macromolecular interaction perturbations in human genetic disorders"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28169297
review:
summary: >-
This study identified interactions between influenza viral proteins and host
proteins including EIF2B4. The biological significance of these interactions
to EIF2B4's core function is unclear.
action: REMOVE
reason: >-
Generic protein binding is uninformative. The viral protein interactions may
represent viral hijacking of the translation machinery but do not inform about
EIF2B4's core molecular function.
supported_by:
- reference_id: PMID:28169297
supporting_text: "Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29599245
review:
summary: >-
Study examining binding of ISRIB to eIF2B complex including EIF2B4.
action: REMOVE
reason: >-
The generic "protein binding" term does not capture the functional relevance.
The ISRIB binding affects eIF2B activity but is better understood in the
context of GEF activity regulation. The small molecule binding is not well
captured by "protein binding."
supported_by:
- reference_id: PMID:29599245
supporting_text: "Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31515488
review:
summary: >-
High-throughput study on protein-protein interactions across human populations.
action: REMOVE
reason: >-
Generic protein binding annotation from high-throughput study is not informative.
More specific molecular function terms are available.
supported_by:
- reference_id: PMID:31515488
supporting_text: "Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: >-
Human binary interactome mapping study.
action: REMOVE
reason: >-
Generic protein binding from high-throughput interactome study is not informative
for annotation purposes. The specific interactions of EIF2B4 within the eIF2B
complex and with eIF2 are better captured by other annotations.
supported_by:
- reference_id: PMID:32296183
supporting_text: "A reference map of the human binary protein interactome"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
review:
summary: >-
Study on interactome mapping in neurodegenerative disease.
action: REMOVE
reason: >-
Generic protein binding is not informative. While EIF2B4 mutations cause
neurodegeneration, the relevant molecular function is its role in the eIF2B
complex with GEF activity, not generic protein binding.
supported_by:
- reference_id: PMID:32814053
supporting_text: "Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
review:
summary: >-
Dual proteome-scale network study on cell-specific interactomes.
action: REMOVE
reason: >-
Generic protein binding is uninformative. Better molecular function terms exist.
supported_by:
- reference_id: PMID:33961781
supporting_text: "Dual proteome-scale networks reveal cell-specific remodeling of the human interactome"
- term:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
evidence_type: IPI
original_reference_id: PMID:29599213
review:
summary: >-
Cryo-EM structural study demonstrating EIF2B4 (delta subunit) is part of the
eIF2B decameric complex. This study solved the atomic structure of the complex.
action: ACCEPT
reason: >-
Excellent experimental evidence from structural studies. PMID:29599213 states
"Formation of fully active, decameric eIF2B holoenzyme depended on the assembly
of two identical tetrameric subcomplexes."
supported_by:
- reference_id: PMID:29599213
supporting_text: "we solved an atomic-resolution structure of ISRIB bound in a deep cleft within decameric human eIF2B by cryo-electron microscopy"
- term:
id: GO:0045948
label: positive regulation of translational initiation
evidence_type: IDA
original_reference_id: PMID:29599213
review:
summary: >-
The eIF2B complex positively regulates translation initiation by catalyzing
GDP-GTP exchange on eIF2, thereby regenerating active eIF2-GTP complexes.
action: ACCEPT
reason: >-
This annotation correctly captures the regulatory role of eIF2B. The deep
research confirms that "eIF2B enables continuous rounds of translation initiation"
by recycling eIF2-GDP to eIF2-GTP.
supported_by:
- reference_id: PMID:29599213
supporting_text: "Formation of fully active, decameric eIF2B holoenzyme depended on the assembly of two identical tetrameric subcomplexes"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-openai.md
supporting_text: "By recycling eIF2-GDP to eIF2-GTP, eIF2B enables continuous rounds of translation initiation"
- term:
id: GO:0002183
label: cytoplasmic translational initiation
evidence_type: IDA
original_reference_id: PMID:27023709
review:
summary: >-
Study on expression and crystallization of S. pombe eIF2B, providing functional
evidence for the role of eIF2B subunits in cytoplasmic translation initiation.
action: ACCEPT
reason: >-
EIF2B4 is part of the eIF2B complex essential for cytoplasmic translation initiation.
The IDA evidence from this study supports the annotation.
supported_by:
- reference_id: PMID:27023709
supporting_text: "Expression, purification, and crystallization of Schizosaccharomyces pombe eIF2B"
- term:
id: GO:0005085
label: guanyl-nucleotide exchange factor activity
evidence_type: IDA
original_reference_id: PMID:25858979
review:
summary: >-
This landmark study identified the target of ISRIB (a memory-enhancing compound)
as eIF2B and confirmed the GEF activity of the complex. Mutations in the delta
subunit affected ISRIB's stimulatory effect on eIF2B GEF activity.
action: ACCEPT
reason: >-
Strong experimental evidence. The study states that ISRIB affected "its stimulatory
effect on eIF2B GEF activity toward its substrate, the translation initiation
factor eIF2, in vitro." Mutations in the delta subunit affected this activity,
demonstrating EIF2B4's contribution to GEF function.
supported_by:
- reference_id: PMID:25858979
supporting_text: "these mutations reversed both ISRIB-mediated inhibition of the ISR and its stimulatory effect on eIF2B GEF activity toward its substrate, the translation initiation factor eIF2, in vitro"
- term:
id: GO:0005085
label: guanyl-nucleotide exchange factor activity
evidence_type: IDA
original_reference_id: PMID:27023709
review:
summary: >-
Study providing functional evidence for eIF2B GEF activity through structural
and biochemical characterization.
action: ACCEPT
reason: >-
Multiple lines of evidence confirm eIF2B's GEF activity. This annotation is
consistent with the well-established function of the eIF2B complex.
supported_by:
- reference_id: PMID:27023709
supporting_text: "Expression, purification, and crystallization of Schizosaccharomyces pombe eIF2B"
- term:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
evidence_type: IDA
original_reference_id: PMID:27023709
review:
summary: >-
Direct evidence for EIF2B4 as a component of the eIF2B complex from
crystallization studies.
action: ACCEPT
reason: >-
Strong experimental evidence from structural studies confirming the delta
subunit's membership in the eIF2B complex.
supported_by:
- reference_id: PMID:27023709
supporting_text: "Expression, purification, and crystallization of Schizosaccharomyces pombe eIF2B"
- term:
id: GO:0050852
label: T cell receptor signaling pathway
evidence_type: IDA
original_reference_id: PMID:8626696
review:
summary: >-
Study showing that T-cell activation leads to rapid stimulation of eIF2B
activity and inactivation of GSK-3. The eIF2B activity increases within 5
minutes of T-cell stimulation.
action: KEEP_AS_NON_CORE
reason: >-
This annotation reflects that eIF2B is regulated downstream of T-cell receptor
signaling through GSK-3 inactivation, rather than EIF2B4 having a direct role
in TCR signaling itself. The study states "The rapid activation of EIF2B
following mitogenic stimulation of T-cells is therefore mediated by factors
other than its own concentration." This is a regulatory context rather than
a direct signaling function.
supported_by:
- reference_id: PMID:8626696
supporting_text: "Mitogenic stimulation of T-lymphocytes causes a rapid activation or protein synthesis... eIF2B activity rises quickly, increasing as early as 5 min after cell stimulation"
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-72670
review:
summary: >-
Reactome pathway annotation for formation of eIF2:GDP:eIF2B intermediate,
which occurs in the cytosol.
action: ACCEPT
reason: >-
The cytosolic localization is consistent with the function in translation
initiation, which occurs in the cytoplasm.
supported_by:
- reference_id: Reactome:R-HSA-72670
supporting_text: "Formation of eIF2:GDP:eIF2B intermediate"
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-72722
review:
summary: >-
Reactome pathway annotation for eIF2 activation, which occurs in the cytosol.
action: ACCEPT
reason: >-
Consistent with cytosolic localization for translation initiation function.
supported_by:
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-openai.md
supporting_text: "The EIF2B4 gene product (eIF2Bdelta) carries out its function in the cytosol, where translation initiation occurs."
- term:
id: GO:0031369
label: translation initiation factor binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
EIF2B4 binds to eIF2 (the substrate of the eIF2B complex) as part of the
nucleotide exchange mechanism. This is inferred from sequence similarity
to rat ortholog.
action: ACCEPT
reason: >-
The deep research confirms that "eIF2 binds across the decameric interface,
engaging the eIF2B alpha subunit, and beta and delta subunits" (PMID:29599213).
This directly demonstrates translation initiation factor binding by EIF2B4.
supported_by:
- reference_id: PMID:29599213
supporting_text: "eIF2 binds across the decameric interface, engaging the eIF2B alpha subunit, and beta and delta subunits from opposing tetramers"
- term:
id: GO:0006413
label: translational initiation
evidence_type: IDA
original_reference_id: PMID:16289705
review:
summary: >-
Study demonstrating that supplementation with eIF2B enhances translation in
mammalian cell-free systems.
action: ACCEPT
reason: >-
Direct experimental evidence showing that eIF2B augments translation.
The study states "eIF2 and eIF2B augmented translation of capped, uncapped
and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs."
supported_by:
- reference_id: PMID:16289705
supporting_text: "eIF2 (eukaryotic translation initiation factor 2) and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs."
- term:
id: GO:0009408
label: response to heat
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
EIF2B is regulated as part of the integrated stress response, which includes
heat stress. Inferred from sequence similarity to rat ortholog.
action: KEEP_AS_NON_CORE
reason: >-
EIF2B4 is part of the eIF2B complex that is regulated during the integrated
stress response. Heat stress causes eIF2alpha phosphorylation, which inhibits
eIF2B activity. This is a response to stress rather than a core function.
The deep research confirms "In response to various stresses (e.g. nutrient
starvation, viral infection, ER stress), specialized kinases... phosphorylate
eIF2 on its alpha subunit."
supported_by:
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-openai.md
supporting_text: "In response to various stresses (e.g. nutrient starvation, viral infection, ER stress), specialized kinases such as PKR, GCN2, PERK, and HRI phosphorylate eIF2 on its alpha subunit at Ser51"
- term:
id: GO:0009408
label: response to heat
evidence_type: TAS
original_reference_id: PMID:12499492
review:
summary: >-
Study describing vanishing white matter disease related to EIF2B5 mutation,
noting that fever (heat stress) triggers neurological deterioration.
action: KEEP_AS_NON_CORE
reason: >-
Heat stress triggers the integrated stress response, which modulates eIF2B
activity. This is a regulatory context rather than a direct function of EIF2B4.
In VWM patients, "additional episodes of rapid deterioration following febrile
infections" are common, demonstrating that heat/fever affects eIF2B-dependent
cells.
supported_by:
- reference_id: PMID:12499492
supporting_text: "A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation"
- term:
id: GO:0014003
label: oligodendrocyte development
evidence_type: IMP
original_reference_id: PMID:15217090
review:
summary: >-
Study on vanishing white matter disease showing that oligodendrocytes are
affected by eIF2B deficiency. The study documents increased oligodendrocyte
density with evidence of both apoptosis and proliferation.
action: KEEP_AS_NON_CORE
reason: >-
The phenotype in VWM disease reflects the high protein synthesis demands of
oligodendrocytes, making them particularly sensitive to eIF2B deficiency.
This is a secondary/pleiotropic effect of impaired translation rather than
a specific developmental role. The study states "Vanishing white matter
disease (VWM) is a progressive cavitating disease of central white matter
due to a deficiency of the translation initiation factor eIF2B."
supported_by:
- reference_id: PMID:15217090
supporting_text: "Vanishing white matter disease (VWM) is a progressive cavitating disease of central white matter due to a deficiency of the translation initiation factor eIF2B. Oligodendrocytes appear to be numerically increased in some white matter areas, while decreased in others."
- term:
id: GO:0003743
label: translation initiation factor activity
evidence_type: IDA
original_reference_id: PMID:16289705
review:
summary: >-
Direct experimental evidence showing eIF2B enhances translation in cell-free
systems. The annotation uses "contributes_to" qualifier, which is appropriate
since the catalytic activity is primarily in the epsilon subunit.
action: ACCEPT
reason: >-
This annotation correctly captures that EIF2B4 contributes to (rather than
directly enables) translation initiation factor activity as part of the
eIF2B complex. The catalytic core is in epsilon/gamma subunits, but the
delta subunit is required for full activity.
supported_by:
- reference_id: PMID:16289705
supporting_text: "eIF2 (eukaryotic translation initiation factor 2) and eIF2B augmented translation of capped, uncapped and encephalomyocarditis virus-internal ribosome entry site-promoted mRNAs."
- term:
id: GO:0009749
label: response to glucose
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
eIF2B activity is regulated by metabolic signals including glucose levels,
through insulin signaling and GSK-3 phosphorylation of eIF2Bepsilon.
action: KEEP_AS_NON_CORE
reason: >-
eIF2B is regulated by metabolic signals but this is not a core function.
The deep research notes that "insulin signaling blocks GSK-3, leading to
Ser535 dephosphorylation and enhanced eIF2B function." This represents
regulation of eIF2B activity by metabolic state rather than a direct
response to glucose by EIF2B4.
supported_by:
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-openai.md
supporting_text: "insulin - through the PI3K/Akt pathway - activates eIF2B by inhibiting GSK-3 kinase"
- term:
id: GO:0043434
label: response to peptide hormone
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
eIF2B activity is modulated by insulin (a peptide hormone) through the
GSK-3 pathway. Inferred from sequence similarity to rat ortholog.
action: KEEP_AS_NON_CORE
reason: >-
eIF2B is regulated downstream of insulin signaling, but this is a
regulatory context rather than a core function of EIF2B4. The annotation
reflects that eIF2B is part of a pathway responding to peptide hormones
rather than directly sensing them.
supported_by:
- reference_id: PMID:8626696
supporting_text: "The largest (epsilon) subunit of eIF2B is a substrate for glycogen synthase kinase-3 (GSK-3), the activity of which rapidly decreases following T-cell activation."
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15060152
review:
summary: >-
Study examining mutations linked to vanishing white matter disease and their
effects on eIF2B complex function and interactions with EIF2B2.
action: REMOVE
reason: >-
Generic protein binding is not informative. The relevant interaction (with
EIF2B2 and other eIF2B subunits) is better captured by the eIF2B complex
membership annotation.
supported_by:
- reference_id: PMID:15060152
supporting_text: "Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways"
- term:
id: GO:0001541
label: ovarian follicle development
evidence_type: IMP
original_reference_id: PMID:15507143
review:
summary: >-
Study screening for EIF2B mutations in patients with premature ovarian failure.
Some EIF2B4 mutations cause ovarioleukodystrophy.
action: KEEP_AS_NON_CORE
reason: >-
The ovarian phenotype in VWM/ovarioleukodystrophy reflects the sensitivity
of rapidly dividing cells to translation defects. UniProt notes that mutations
cause "ovarian failure" and "ovarioleukodystrophy." However, this is a
secondary effect of impaired global translation rather than a specific
role in ovarian development.
supported_by:
- reference_id: PMID:15507143
supporting_text: "Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure"
- reference_id: PMID:39139316
supporting_text: "This resulted in a series of 20 cases of women with ovarioleukodystrophy due to variants in the EIF2B gene complex. The median age of onset was 19 years (range 0.6-40). The clinical features present in the entire sample were WM involvement and ovarian changes, the latter corresponding to ovarian dysgenesis (5%), primary amenorrhea (15%), secondary amenorrhea (15%), and premature ovarian failure (60%)"
- term:
id: GO:0005085
label: guanyl-nucleotide exchange factor activity
evidence_type: IDA
original_reference_id: PMID:11323413
review:
summary: >-
Seminal study characterizing mammalian eIF2B as a GDP dissociation stimulator
protein. Demonstrated that eIF2B can mediate release of eIF2-bound GDP.
action: ACCEPT
reason: >-
Strong experimental evidence. The study directly demonstrates GEF activity:
"mammalian eIF2B can mediate release of eIF2-bound GDP even in the absence
of free nucleotide, indicating that it acts as a GDP dissociation stimulator
protein." Note: the annotation uses "contributes_to" qualifier, which is
appropriate as catalytic activity is primarily in epsilon subunit.
supported_by:
- reference_id: PMID:11323413
supporting_text: "mammalian eIF2B can mediate release of eIF2-bound GDP even in the absence of free nucleotide, indicating that it acts as a GDP dissociation stimulator protein"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
supporting_text: "eIF2B's catalytic function is mainly attributed to the γ and ε subunits, while α/β/δ enhance full activity and provide regulatory control, including stress sensitivity"
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:11323413
review:
summary: >-
Study demonstrating eIF2B function in the cytoplasm through biochemical
characterization of the complex.
action: ACCEPT
reason: >-
The cytoplasmic localization is well-established and consistent with the
function in translation initiation, which occurs in the cytoplasm.
supported_by:
- reference_id: PMID:11323413
supporting_text: "Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein"
- term:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
evidence_type: IDA
original_reference_id: PMID:11323413
review:
summary: >-
Study characterizing the five-subunit eIF2B complex, confirming EIF2B4
(delta) as a component.
action: ACCEPT
reason: >-
Direct experimental evidence. The study states "It is composed of five
subunits, alpha-epsilon."
supported_by:
- reference_id: PMID:11323413
supporting_text: "It is composed of five subunits, alpha-epsilon."
- reference_id: PMID:24532666
supporting_text: "is actually decameric, a dimer of eIF2B(βγδε) tetramers stabilized by 2 copies"
- term:
id: GO:0042552
label: myelination
evidence_type: IMP
original_reference_id: PMID:14566705
review:
summary: >-
Study on eIF2B-related disorders showing that mutations cause myelination
defects. Vanishing white matter disease involves loss of myelin.
action: KEEP_AS_NON_CORE
reason: >-
The myelination phenotype in VWM reflects the high protein synthesis demands
of myelinating oligodendrocytes. This is a secondary/pleiotropic effect of
impaired translation rather than a direct role in myelination. The annotation
is valid as a mutant phenotype but not a core function of EIF2B4.
supported_by:
- reference_id: PMID:14566705
supporting_text: "eIF2B-related disorders: antenatal onset and involvement of multiple organs"
- term:
id: GO:0005085
label: guanyl-nucleotide exchange factor activity
evidence_type: IMP
original_reference_id: PMID:15054402
review:
summary: >-
Study measuring GEF activity in cells from patients with eIF2B mutations.
Demonstrated 20-70% decrease in GEF activity in mutated cells.
action: ACCEPT
reason: >-
Strong functional evidence. The study states "A significant decrease of
20-70% in GEF activity was observed in all mutated cells." This demonstrates
that EIF2B4 mutations affect GEF activity. Uses "contributes_to" qualifier
appropriately.
supported_by:
- reference_id: PMID:15054402
supporting_text: "A significant decrease of 20-70% in GEF activity was observed in all mutated cells. The severity of this decrement of GEF activity correlated with age at onset of the disease."
- term:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
evidence_type: IDA
original_reference_id: PMID:15060152
review:
summary: >-
Study on mutations affecting eIF2B complex function, confirming EIF2B4
as a component of the complex.
action: ACCEPT
reason: >-
Direct experimental evidence from studies of the eIF2B complex.
supported_by:
- reference_id: PMID:15060152
supporting_text: "Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways"
- term:
id: GO:0006417
label: regulation of translation
evidence_type: NAS
original_reference_id: PMID:12556349
review:
summary: >-
Study showing that reduced amino acid availability inhibits muscle protein
synthesis and decreases eIF2B activity.
action: ACCEPT
reason: >-
eIF2B is a key regulator of translation. The deep research confirms that
"eIF2B activity is regulated during the integrated stress response" and
"By assembling these subunits, eIF2B serves as the sole guanine nucleotide
exchange factor (GEF) for eIF2, playing a pivotal role in recycling eIF2
for continued protein synthesis."
supported_by:
- reference_id: PMID:12556349
supporting_text: "Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B"
- reference_id: PMID:36943285
supporting_text: "Phosphorylation of eIF2α (p-eIF2α) blocks the eIF2B-directed exchange, consequently reducing the levels of eIF2•GTP that are required for delivery of methionyl initiator tRNA"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
supporting_text: "phosphorylated eIF2α binds eIF2B in a way that blocks productive engagement of eIF2γ with the catalytic ε subunit, suppressing nucleotide exchange"
core_functions:
- molecular_function:
id: GO:0005085
label: guanyl-nucleotide exchange factor activity
in_complex:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
directly_involved_in:
- id: GO:0002183
label: cytoplasmic translational initiation
locations:
- id: GO:0005829
label: cytosol
description: >-
EIF2B4 (delta subunit) is part of the regulatory subcomplex of eIF2B, which
catalyzes GDP-GTP exchange on eIF2. While the catalytic activity resides in
the epsilon subunit, the delta subunit is essential for full GEF activity
of the holoenzyme. PMID:11323413 demonstrates that "mammalian eIF2B can
mediate release of eIF2-bound GDP" and PMID:15054402 shows that mutations
in eIF2B subunits (including delta) cause 20-70% decrease in GEF activity.
supported_by:
- reference_id: PMID:11323413
supporting_text: "mammalian eIF2B can mediate release of eIF2-bound GDP even in the absence of free nucleotide, indicating that it acts as a GDP dissociation stimulator protein"
- reference_id: PMID:15054402
supporting_text: "A significant decrease of 20-70% in GEF activity was observed in all mutated cells"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
supporting_text: "eIF2B's catalytic function is mainly attributed to the γ and ε subunits, while α/β/δ enhance full activity and provide regulatory control, including stress sensitivity"
- molecular_function:
id: GO:0031369
label: translation initiation factor binding
in_complex:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
directly_involved_in:
- id: GO:0006417
label: regulation of translation
locations:
- id: GO:0005829
label: cytosol
description: >-
EIF2B4/eIF2Bdelta forms a key interface for binding phosphorylated eIF2alpha
during the integrated stress response. Phospho-eIF2alpha binds eIF2B at an
interface that includes the alpha and delta subunits, blocking productive
engagement of eIF2gamma with the catalytic epsilon subunit and thereby
suppressing nucleotide exchange. This inhibitory interaction converts
phospho-eIF2 into a competitive inhibitor of eIF2B, providing the molecular
basis for ISR-mediated translational reprogramming.
supported_by:
- reference_id: PMID:29599213
supporting_text: "eIF2 binds across the decameric interface, engaging the eIF2B alpha subunit, and beta and delta subunits from opposing tetramers"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
supporting_text: "phosphorylated eIF2α binds eIF2B in a way that blocks productive engagement of eIF2γ with the catalytic ε subunit, suppressing nucleotide exchange"
- reference_id: PMID:36943285
supporting_text: "Phosphorylation of eIF2α (p-eIF2α) blocks the eIF2B-directed exchange, consequently reducing the levels of eIF2•GTP"
- molecular_function:
id: GO:0005085
label: guanyl-nucleotide exchange factor activity
in_complex:
id: GO:0005851
label: eukaryotic translation initiation factor 2B complex
directly_involved_in:
- id: GO:0006413
label: translational initiation
locations:
- id: GO:0005829
label: cytosol
description: >-
EIF2B4/eIF2Bdelta serves as a regulatory/scaffold subunit essential for assembly
and stabilization of the decameric eIF2B holoenzyme that catalyzes GEF activity.
The delta subunit, together with beta, forms the beta/delta core that supports
higher-order assembly of eIF2B and is central to allosteric regulation by small
molecules such as ISRIB. delta contributes to inter-subcomplex organization and
proper stress-sensitive regulatory behavior of the holoenzyme; full GEF activity
requires the assembled decamer.
supported_by:
- reference_id: PMID:24532666
supporting_text: "is actually decameric, a dimer of eIF2B(βγδε) tetramers stabilized by 2 copies"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
supporting_text: "participates in assembly and stabilization of the full decameric eIF2B complex"
- reference_id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
supporting_text: "contributes to the β/δ \"core\" that supports higher-order assembly of eIF2B and is central to allosteric regulation by small molecules"
references:
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity.
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: PMID:11323413
title: Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein.
findings:
- statement: Demonstrated that eIF2B acts as a GDP dissociation stimulator protein
supporting_text: "mammalian eIF2B can mediate release of eIF2-bound GDP even in the absence of free nucleotide, indicating that it acts as a GDP dissociation stimulator protein"
- statement: Showed that all five subunits contribute to full activity
supporting_text: "It is composed of five subunits, alpha-epsilon."
- statement: Confirmed eIF2B mediates release of eIF2-bound GDP
supporting_text: "Initiation factor eIF2B mediates a key regulatory step in the initiation of mRNA translation, i.e. the regeneration of active eIF2.GTP complexes."
- id: PMID:12499492
title: A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.
findings:
- statement: Described severe VWM variant triggered by fever
supporting_text: "A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy"
- id: PMID:12556349
title: Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B.
findings:
- statement: Showed eIF2B activity is regulated by amino acid availability
supporting_text: "Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B"
- id: PMID:14566705
title: 'eIF2B-related disorders: antenatal onset and involvement of multiple organs.'
findings:
- statement: Described severe prenatal forms of eIF2B-related disease
supporting_text: "eIF2B-related disorders: antenatal onset and involvement of multiple organs"
- statement: Showed multi-organ involvement
supporting_text: "eIF2B-related disorders: antenatal onset and involvement of multiple organs"
- id: PMID:15054402
title: Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
findings:
- statement: Measured 20-70% decrease in GEF activity in patient cells
supporting_text: "A significant decrease of 20-70% in GEF activity was observed in all mutated cells"
- statement: Correlated GEF activity decrease with disease severity
supporting_text: "The severity of this decrement of GEF activity correlated with age at onset of the disease"
- id: PMID:15060152
title: Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways.
findings:
- statement: Characterized functional effects of VWM mutations on eIF2B
supporting_text: "Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways"
- id: PMID:15217090
title: The life and death of oligodendrocytes in vanishing white matter disease.
findings:
- statement: Documented oligodendrocyte pathology in VWM
supporting_text: "Vanishing white matter disease (VWM) is a progressive cavitating disease of central white matter due to a deficiency of the translation initiation factor eIF2B"
- statement: Showed both apoptosis and proliferation of oligodendrocytes
supporting_text: "Oligodendrocytes appear to be numerically increased in some white matter areas, while decreased in others"
- id: PMID:15507143
title: Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure.
findings:
- statement: Linked EIF2B mutations to premature ovarian failure
supporting_text: "Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure"
- id: PMID:16289705
title: An efficient mammalian cell-free translation system supplemented with translation factors.
findings:
- statement: Demonstrated eIF2B augments translation in cell-free systems
- statement: Showed eIF2 and eIF2B enhance mRNA translation
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings:
- statement: High-throughput interactome mapping
- id: PMID:25858979
title: Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound.
findings:
- statement: Identified eIF2B as the target of ISRIB
- statement: Showed mutations in delta subunit affect ISRIB response
- statement: Demonstrated ISRIB stimulates eIF2B GEF activity
- id: PMID:25910212
title: Widespread macromolecular interaction perturbations in human genetic disorders.
findings:
- statement: Protein interaction study
- id: PMID:27023709
title: Expression, purification, and crystallization of Schizosaccharomyces pombe eIF2B.
findings:
- statement: Structural characterization of eIF2B
- id: PMID:28169297
title: Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction.
findings:
- statement: Identified viral protein interactions with eIF2B subunits
- id: PMID:29599213
title: Structure of the nucleotide exchange factor eIF2B reveals mechanism of memory-enhancing molecule.
findings:
- statement: Solved atomic structure of human eIF2B with ISRIB
- statement: Showed decameric assembly is required for full activity
- statement: Demonstrated ISRIB stabilizes decameric form
- id: PMID:29599245
title: Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B.
findings:
- statement: Characterized ISRIB binding site on eIF2B
- id: PMID:31515488
title: Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.
findings:
- statement: Protein interaction study
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings:
- statement: Binary interactome mapping
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
findings:
- statement: Neurodegenerative disease interactome
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
findings:
- statement: Cell-specific interactome study
- id: PMID:8626696
title: T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3.
findings:
- statement: Showed eIF2B is rapidly activated after T-cell stimulation
- statement: Linked GSK-3 inactivation to eIF2B activation
- id: Reactome:R-HSA-72670
title: Formation of eIF2:GDP:eIF2B intermediate
findings:
- statement: Pathway annotation for eIF2B function
- id: Reactome:R-HSA-72722
title: eIF2 activation
findings:
- statement: Pathway annotation for eIF2 activation by eIF2B
- id: file:human/EIF2B4/EIF2B4-deep-research-openai.md
title: Deep research on EIF2B4 function
findings:
- statement: Comprehensive review of eIF2B structure and function
- statement: Documented role in integrated stress response
- statement: Described subcellular localization to cytosol and eIF2B bodies
- id: file:human/EIF2B4/EIF2B4-deep-research-falcon.md
title: Falcon deep research on EIF2B4 function
findings:
- statement: EIF2B4/eIF2Bdelta is a regulatory/scaffold subunit (not catalytic) that supports decameric holoenzyme assembly and contributes to the beta/delta core central to allosteric regulation
supporting_text: "eIF2B's catalytic function is mainly attributed to the γ and ε subunits, while α/β/δ enhance full activity and provide regulatory control, including stress sensitivity"
- statement: Phospho-eIF2alpha binds an interface that includes EIF2B4 (delta) and blocks engagement of eIF2gamma with the catalytic epsilon subunit
supporting_text: "phosphorylated eIF2α binds eIF2B in a way that blocks productive engagement of eIF2γ with the catalytic ε subunit, suppressing nucleotide exchange"
- statement: eIF2B localizes to discrete cytoplasmic eIF2B bodies with cell-type-specific composition
supporting_text: "eIF2B localizes to discrete cytoplasmic foci called eIF2B bodies, which are interpreted as sites of eIF2B GEF activity and exhibit cell-type-specific composition in neuronal and glial cell lines"
- id: PMID:24532666
title: Analysis of the subunit organization of the eIF2B complex reveals new insights into its structure and regulation.
findings:
- statement: Established eIF2B as heterodecamer that is a dimer of tetramers stabilized by additional subunits
supporting_text: "is actually decameric, a dimer of eIF2B(βγδε) tetramers stabilized by 2 copies"
- id: PMID:36943285
title: 'Surviving and Adapting to Stress: Translational Control and the Integrated Stress Response.'
findings:
- statement: Authoritative ISR review documenting that eIF2alpha phosphorylation inhibits eIF2B GEF activity
supporting_text: "Phosphorylation of eIF2α (p-eIF2α) blocks the eIF2B-directed exchange, consequently reducing the levels of eIF2•GTP that are required for delivery of methionyl initiator tRNA"
- id: PMID:37014850
title: eIF2Bdelta blocks the integrated stress response and maintains eIF2B activity and cancer metastasis by overexpression in breast cancer stem cells.
findings:
- statement: Elevated eIF2Bdelta supports cancer stem cell metastasis through ISR suppression
- id: PMID:39139316
title: 'Ovarioleukodystrophy Due to EIF2B Genes: Systematic Review and Case Report.'
findings:
- statement: Systematic review of 20 worldwide ovarioleukodystrophy cases highlighting EIF2B4 involvement
supporting_text: "This resulted in a series of 20 cases of women with ovarioleukodystrophy due to variants in the EIF2B gene complex. The median age of onset was 19 years (range 0.6-40)"
- statement: Reported new case with homozygous EIF2B4 c.725C>T (p.Pro242Leu)
supporting_text: "identified the variant c.725C>T (NM_015636.3; p.Pro242Leu) in the EIF2B4 gene in a homozygous state"
- id: PMID:39310746
title: eIF2B localization and its regulation during the integrated stress response is cell-type specific.
findings:
- statement: eIF2B localization during the ISR is cell-type specific
supporting_text: "eIF2B localization and its regulation during the integrated stress response is cell-type specific"
- id: PMID:37981684
title: Genotypic and phenotypic heterogeneity among Chinese pediatric genetic white matter disorders.
findings:
- statement: Pediatric cohort identifying EIF2B4 in patients with white matter disorders
status: COMPLETE